MedMij:V1.0 AddendaInhoudelijkeGegevens: verschil tussen versies
Naar navigatie springen
Naar zoeken springen
Geen bewerkingssamenvatting |
Geen bewerkingssamenvatting |
||
| Regel 6: | Regel 6: | ||
==Patiënt J. XXX_Amaya== | ==Patiënt J. XXX_Amaya== | ||
<section begin=XXX_Amaya /> | <section begin=XXX_Amaya /> | ||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patient | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Naamgegevens | ||
|style="background-color: white;"|J. XXX_Amaya | |style="background-color: white;"|J. XXX_Amaya | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Patient identificatienummer | ||
|style="background-color: white;"|999911764 [BSN] | |style="background-color: white;"|999911764 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Patient identificatienummer | ||
|style="background-color: white;"|51107 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | |style="background-color: white;"|51107 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geboortedatum | ||
|style="background-color: white;"|6 aug 1964 | |style="background-color: white;"|6 aug 1964 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geslacht | ||
|style="background-color: white;"|Man (code = 'M') | |style="background-color: white;"|Man (code = 'M') | ||
|}<section end=XXX_Amaya /> | |}<section end=XXX_Amaya /> | ||
| Regel 31: | Regel 31: | ||
<section begin=MA_XXX_Amaya /> | <section begin=MA_XXX_Amaya /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_513_1_MA_1 | |style="background-color: white;"|MBH_513_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|2 sep 2018, om 11:25 | |style="background-color: white;"|2 sep 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 2 sep 2018, gedurende 60 dagen | |style="background-color: white;"|Vanaf 2 sep 2018, gedurende 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geannuleerd indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 2 sep 2018, gedurende 60 dagen, 10 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 2 sep 2018, gedurende 60 dagen, 10 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|10 maal per dag 1 stuk | |style="background-color: white;"|10 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_513_1 | |style="background-color: white;"|MBH_513_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_513_1_MA_2 | |style="background-color: white;"|MBH_513_1_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|3 sep 2018, om 09:00 | |style="background-color: white;"|3 sep 2018, om 09:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_513_1 | |style="background-color: white;"|MBH_513_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_513_2_MA_2 | |style="background-color: white;"|MBH_513_2_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|3 sep 2018, om 14:32 | |style="background-color: white;"|3 sep 2018, om 14:32 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar afspraak of gebruik: TA | ||
|style="background-color: white;"|MBH_513_2_TA_1 | |style="background-color: white;"|MBH_513_2_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Opname (code = '305335007') | |style="background-color: white;"|Opname (code = '305335007') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Furosemide tablet 40mg | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, 1 maal daags 1 stuk, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, 1 maal daags 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Toelichting | ||
|style="background-color: white;"|Toedieningsafspraak van apotheker ontvangen, geen medicatieafspraak van voorschrijver ontvangen. Deze nieuwe medicatieafspraak is gebaseerd op de toedieningsafspraak: MBH_513_2_TA_1 | |style="background-color: white;"|Toedieningsafspraak van apotheker ontvangen, geen medicatieafspraak van voorschrijver ontvangen. Deze nieuwe medicatieafspraak is gebaseerd op de toedieningsafspraak: MBH_513_2_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_513_2 | |style="background-color: white;"|MBH_513_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_513_3_MA_1 | |style="background-color: white;"|MBH_513_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|3 sep 2018, om 14:32 | |style="background-color: white;"|3 sep 2018, om 14:32 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 28 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 28 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar afspraak of gebruik: MGB | ||
|style="background-color: white;"|MBH_513_3_MGB_1 | |style="background-color: white;"|MBH_513_3_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Opname (code = '305335007') | |style="background-color: white;"|Opname (code = '305335007') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden van voorschrijven | ||
|style="background-color: white;"|Andere maligniteit bloed/lymfestelsel (code = 'B74') | |style="background-color: white;"|Andere maligniteit bloed/lymfestelsel (code = 'B74') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Methotrexaat tablet 2,5mg | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 28 dagen, 1 maal per week 5 stuks, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 28 dagen, 1 maal per week 5 stuks, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per week 5 stuks | |style="background-color: white;"|1 maal per week 5 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_513_3 | |style="background-color: white;"|MBH_513_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_513_4_MA_1 | |style="background-color: white;"|MBH_513_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|29 aug 2018, om 09:35 | |style="background-color: white;"|29 aug 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 29 aug 2018, gedurende 10 dagen | |style="background-color: white;"|Vanaf 29 aug 2018, gedurende 10 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 29 aug 2018, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 29 aug 2018, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|3 maal per dag 1 stuk | |style="background-color: white;"|3 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Lichaamslengte | ||
|style="background-color: white;"|155 cm | |style="background-color: white;"|155 cm | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Lichaamsgewicht | ||
|style="background-color: white;"|54 kg | |style="background-color: white;"|54 kg | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Aanvullende informatie | ||
|style="background-color: white;"|Bewust hoge dosering (code = '1') | |style="background-color: white;"|Bewust hoge dosering (code = '1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Toelichting | ||
|style="background-color: white;"|In overleg met specialist | |style="background-color: white;"|In overleg met specialist | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_513_4 | |style="background-color: white;"|MBH_513_4 | ||
|}<section end=MA_XXX_Amaya /> | |}<section end=MA_XXX_Amaya /> | ||
| Regel 265: | Regel 265: | ||
<section begin=VV_XXX_Amaya /> | <section begin=VV_XXX_Amaya /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_513_2_VV_2 | |style="background-color: white;"|MBH_513_2_VV_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Datum | ||
|style="background-color: white;"|16 aug 2018, om 14:32 | |style="background-color: white;"|16 aug 2018, om 14:32 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Hans van Doorn - Huisartsen, niet nader gespecificeerd. Ziekenhuis Stitswerd | |style="background-color: white;"|Hans van Doorn - Huisartsen, niet nader gespecificeerd. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Te verstrekken hoeveelheid | ||
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Furosemide tablet 40mg | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Beoogd verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Toelichting | ||
|style="background-color: white;"|Nog in te vullen, zie word... | |style="background-color: white;"|Nog in te vullen, zie word... | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_513_2_MA_2 | |style="background-color: white;"|MBH_513_2_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_513_2 | |style="background-color: white;"|MBH_513_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_513_4_VV_1 | |style="background-color: white;"|MBH_513_4_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Datum | ||
|style="background-color: white;"|11 aug 2018, om 09:35 | |style="background-color: white;"|11 aug 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Te verstrekken hoeveelheid | ||
|style="background-color: white;"|40 stuks | |style="background-color: white;"|40 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Beoogd verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afleverlocatie | ||
|style="background-color: white;"|Huisadres patiënt | |style="background-color: white;"|Huisadres patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Aanvullende wensen | ||
|style="background-color: white;"|Bezorgen (code = '3') | |style="background-color: white;"|Bezorgen (code = '3') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_513_4_MA_1 | |style="background-color: white;"|MBH_513_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_513_4 | |style="background-color: white;"|MBH_513_4 | ||
|}<section end=VV_XXX_Amaya /> | |}<section end=VV_XXX_Amaya /> | ||
| Regel 338: | Regel 338: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_513_1_TA_1 | |style="background-color: white;"|MBH_513_1_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|3 sep 2018, om 12:25 | |style="background-color: white;"|3 sep 2018, om 12:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geannuleerd indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_513_1_MA_2 | |style="background-color: white;"|MBH_513_1_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_513_1 | |style="background-color: white;"|MBH_513_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_513_2_TA_1 | |style="background-color: white;"|MBH_513_2_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|27 aug 2018, om 14:52 | |style="background-color: white;"|27 aug 2018, om 14:52 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 27 aug 2018, tot nader order | |style="background-color: white;"|Vanaf 27 aug 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Opname | |style="background-color: white;"|Opname | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|FUROSEMIDE ACTAVIS TABLET 40MG | |style="background-color: white;"|FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 27 aug 2018, tot nader order, 1 maal daags 1 stuk, oraal | |style="background-color: white;"|Vanaf 27 aug 2018, tot nader order, 1 maal daags 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_513_2_MA_1 | |style="background-color: white;"|MBH_513_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_513_2 | |style="background-color: white;"|MBH_513_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_513_4_TA_1 | |style="background-color: white;"|MBH_513_4_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|29 aug 2018, om 09:45 | |style="background-color: white;"|29 aug 2018, om 09:45 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 29 aug 2018, gedurende 10 dagen | |style="background-color: white;"|Vanaf 29 aug 2018, gedurende 10 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|AMOXICILLINE PCH CAPSULE 500MG | |style="background-color: white;"|AMOXICILLINE PCH CAPSULE 500MG (code = '646083') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 29 aug 2018, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 29 aug 2018, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|3 maal per dag 1 stuk | |style="background-color: white;"|3 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Aanvullende informatie | ||
|style="background-color: white;"|Gebruiksinstructie gegeven (code = '10') | |style="background-color: white;"|Gebruiksinstructie gegeven (code = '10') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Toelichting | ||
|style="background-color: white;"|Wegens niet leverbaar zijn van Broxil | |style="background-color: white;"|Wegens niet leverbaar zijn van Broxil | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_513_4_MA_1 | |style="background-color: white;"|MBH_513_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_513_4 | |style="background-color: white;"|MBH_513_4 | ||
|} | |} | ||
| Regel 475: | Regel 475: | ||
<section begin=MVE_XXX_Amaya /> | <section begin=MVE_XXX_Amaya /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_513_2_MVE_1 | |style="background-color: white;"|MBH_513_2_MVE_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Aanschrijfdatum | ||
|style="background-color: white;"|3 sep 2018, om 14:32 | |style="background-color: white;"|3 sep 2018, om 14:32 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekte hoeveelheid | ||
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|FUROSEMIDE ACTAVIS TABLET 40MG | |style="background-color: white;"|FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar verstrekkingsverzoek | ||
|style="background-color: white;"|MBH_513_2_VV_2 | |style="background-color: white;"|MBH_513_2_VV_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_513_2 | |style="background-color: white;"|MBH_513_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_513_4_MVE_1 | |style="background-color: white;"|MBH_513_4_MVE_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Datum | ||
|style="background-color: white;"|29 aug 2018, om 09:45 | |style="background-color: white;"|29 aug 2018, om 09:45 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekte hoeveelheid | ||
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|AMOXICILLINE PCH CAPSULE 500MG | |style="background-color: white;"|AMOXICILLINE PCH CAPSULE 500MG (code = '646083') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afleverlocatie | ||
|style="background-color: white;"|Huisadres patiënt | |style="background-color: white;"|Huisadres patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Aanvullende informatie | ||
|style="background-color: white;"|Aantal bewust gewijzigd (code = '1') | |style="background-color: white;"|Aantal bewust gewijzigd (code = '1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Toelichting | ||
|style="background-color: white;"|Patiënt gaf aan nog wat op voorraad te hebben, wens patiënt om minder te verstrekken. | |style="background-color: white;"|Patiënt gaf aan nog wat op voorraad te hebben, wens patiënt om minder te verstrekken. | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar verstrekkingsverzoek | ||
|style="background-color: white;"|MBH_513_4_VV_1 | |style="background-color: white;"|MBH_513_4_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_513_4 | |style="background-color: white;"|MBH_513_4 | ||
|}<section end=MVE_XXX_Amaya /> | |}<section end=MVE_XXX_Amaya /> | ||
| Regel 542: | Regel 542: | ||
<section begin=MGB_XXX_Amaya /> | <section begin=MGB_XXX_Amaya /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_513_2_MGB_1 | |style="background-color: white;"|MBH_513_2_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|1 sep 2018, om 15:39 | |style="background-color: white;"|1 sep 2018, om 15:39 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 1 sep 2018, tot nader order | |style="background-color: white;"|Vanaf 1 sep 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Furosemide tablet 40mg | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 1 sep 2018, tot nader order, 1 maal daags 1 stuk, oraal | |style="background-color: white;"|Vanaf 1 sep 2018, tot nader order, 1 maal daags 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_513_2_MA_1 | |style="background-color: white;"|MBH_513_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_513_2 | |style="background-color: white;"|MBH_513_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_513_2_MGB_2 | |style="background-color: white;"|MBH_513_2_MGB_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|3 sep 2018, om 20:40 | |style="background-color: white;"|3 sep 2018, om 20:40 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 2 sep 2018, tot nader order | |style="background-color: white;"|Vanaf 2 sep 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Furosemide tablet 40mg | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 2 sep 2018, tot nader order, 1 maal daags 1 stuk, oraal | |style="background-color: white;"|Vanaf 2 sep 2018, tot nader order, 1 maal daags 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_513_2_MA_1 | |style="background-color: white;"|MBH_513_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Informant | ||
|style="background-color: white;"|Persoon: M. XXX_Amaya - Mantelzorger. | |style="background-color: white;"|Persoon: M. XXX_Amaya - Mantelzorger. | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_513_2 | |style="background-color: white;"|MBH_513_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_513_2_MGB_3 | |style="background-color: white;"|MBH_513_2_MGB_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|3 sep 2018, om 21:39 | |style="background-color: white;"|3 sep 2018, om 21:39 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Furosemide tablet 40mg | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, 1 maal daags 1 stuk, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, 1 maal daags 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_513_2_MA_1 | |style="background-color: white;"|MBH_513_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Informant | ||
|style="background-color: white;"|Zorgverlener: Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Zorgverlener: Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_513_2 | |style="background-color: white;"|MBH_513_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_5132_2_MGB_2 | |style="background-color: white;"|MBH_5132_2_MGB_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|16 aug 2018, om 20:59 | |style="background-color: white;"|16 aug 2018, om 20:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 16 aug 2018, gedurende 1 dag | |style="background-color: white;"|Vanaf 16 aug 2018, gedurende 1 dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|TEMAZEPAM APOTEX TABLET 10MG | |style="background-color: white;"|TEMAZEPAM APOTEX TABLET 10MG (code = '13806769') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf T, gedurende 1 dag, 1 maal daags 1 stuk, oraal | |style="background-color: white;"|Vanaf T, gedurende 1 dag, 1 maal daags 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde verstrekking | ||
|style="background-color: white;"|MBH_5132_2_MVE_1 | |style="background-color: white;"|MBH_5132_2_MVE_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_5132_2 | |style="background-color: white;"|MBH_5132_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_513_3_MGB_1 | |style="background-color: white;"|MBH_513_3_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|31 aug 2018, om 20:59 | |style="background-color: white;"|31 aug 2018, om 20:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 26 aug 2018, tot en met 31 aug 2018 23:59 | |style="background-color: white;"|Vanaf 26 aug 2018, tot en met 31 aug 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Methotrexaat tablet 2,5mg | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 26 aug 2018 tot en met 31 aug 2018, 1 maal per week 5 stuks, oraal | |style="background-color: white;"|Vanaf 26 aug 2018 tot en met 31 aug 2018, 1 maal per week 5 stuks, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per week 5 stuks | |style="background-color: white;"|1 maal per week 5 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_513_3_MA_1 | |style="background-color: white;"|MBH_513_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden gebruik | ||
|style="background-color: white;"|Lymfekanker | |style="background-color: white;"|Lymfekanker | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_513_3 | |style="background-color: white;"|MBH_513_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_513_4_MGB_1 | |style="background-color: white;"|MBH_513_4_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|30 aug 2018, om 22:35 | |style="background-color: white;"|30 aug 2018, om 22:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Volgens afspraak indicator | ||
|style="background-color: white;"|False | |style="background-color: white;"|False | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 29 aug 2018, tot en met 30 aug 2018 23:59 | |style="background-color: white;"|Vanaf 29 aug 2018, tot en met 30 aug 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|AMOXICILLINE CAPSULE 250MG | |style="background-color: white;"|AMOXICILLINE CAPSULE 250MG (code = '20044') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 29 aug 2018 tot en met 30 aug 2018, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 29 aug 2018 tot en met 30 aug 2018, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_513_4_MA_1 | |style="background-color: white;"|MBH_513_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_513_4 | |style="background-color: white;"|MBH_513_4 | ||
|}<section end=MGB_XXX_Amaya /> | |}<section end=MGB_XXX_Amaya /> | ||
==Patiënt Pauline P. XXX_Bourgonje== | ==Patiënt Pauline P. XXX_Bourgonje== | ||
<section begin=XXX_Bourgonje /> | <section begin=XXX_Bourgonje /> | ||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patient | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Naamgegevens | ||
|style="background-color: white;"|Pauline P. XXX_Bourgonje | |style="background-color: white;"|Pauline P. XXX_Bourgonje | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Patient identificatienummer | ||
|style="background-color: white;"|999911296 [BSN] | |style="background-color: white;"|999911296 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Patient identificatienummer | ||
|style="background-color: white;"|12102 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | |style="background-color: white;"|12102 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geboortedatum | ||
|style="background-color: white;"|1 aug 1964 | |style="background-color: white;"|1 aug 1964 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F') | |style="background-color: white;"|Vrouw (code = 'F') | ||
|}<section end=XXX_Bourgonje /> | |}<section end=XXX_Bourgonje /> | ||
| Regel 850: | Regel 850: | ||
<section begin=MA_XXX_Bourgonje /> | <section begin=MA_XXX_Bourgonje /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_123_1_MA_1 | |style="background-color: white;"|MBH_123_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|27 aug 2018, om | |style="background-color: white;"|27 aug 2018, om | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 27 aug 2018, tot nader order | |style="background-color: white;"|Vanaf 27 aug 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 27 aug 2018, Zo nodig 2 maal daags aanbrengen, op de huid | |style="background-color: white;"|Vanaf 27 aug 2018, Zo nodig 2 maal daags aanbrengen, op de huid | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Cutaan (code = '53') | |style="background-color: white;"|Cutaan (code = '53') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
|style="background-color: white;"|Aanbrengen (code = '1018') | |style="background-color: white;"|Aanbrengen (code = '1018') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|Zo nodig 2 maal per dag | |style="background-color: white;"|Zo nodig 2 maal per dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_123_1 | |style="background-color: white;"|MBH_123_1 | ||
|}<section end=MA_XXX_Bourgonje /> | |}<section end=MA_XXX_Bourgonje /> | ||
| Regel 896: | Regel 896: | ||
<section begin=VV_XXX_Bourgonje /> | <section begin=VV_XXX_Bourgonje /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_123_1_VV_1 | |style="background-color: white;"|MBH_123_1_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Datum | ||
|style="background-color: white;"|27 aug 2018, om | |style="background-color: white;"|27 aug 2018, om | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Te verstrekken hoeveelheid | ||
|style="background-color: white;"|100 gram | |style="background-color: white;"|100 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Beoogd verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_123_1_MA_1 | |style="background-color: white;"|MBH_123_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_123_1 | |style="background-color: white;"|MBH_123_1 | ||
|}<section end=VV_XXX_Bourgonje /> | |}<section end=VV_XXX_Bourgonje /> | ||
| Regel 929: | Regel 929: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_123_1_TA_1 | |style="background-color: white;"|MBH_123_1_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|27 aug 2018, om 00:00 | |style="background-color: white;"|27 aug 2018, om 00:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 27 aug 2018, tot nader order | |style="background-color: white;"|Vanaf 27 aug 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON | |style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 27 aug 2018, Zo nodig 2 maal daags aanbrengen, op de huid | |style="background-color: white;"|Vanaf 27 aug 2018, Zo nodig 2 maal daags aanbrengen, op de huid | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Cutaan (code = '53') | |style="background-color: white;"|Cutaan (code = '53') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
|style="background-color: white;"|Aanbrengen (code = '1018') | |style="background-color: white;"|Aanbrengen (code = '1018') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|Zo nodig 2 maal per dag | |style="background-color: white;"|Zo nodig 2 maal per dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_123_1_MA_1 | |style="background-color: white;"|MBH_123_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_123_1 | |style="background-color: white;"|MBH_123_1 | ||
|} | |} | ||
| Regel 975: | Regel 975: | ||
<section begin=MVE_XXX_Bourgonje /> | <section begin=MVE_XXX_Bourgonje /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_123_1_MVE_1 | |style="background-color: white;"|MBH_123_1_MVE_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Datum | ||
|style="background-color: white;"|27 aug 2018, om | |style="background-color: white;"|27 aug 2018, om | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekte hoeveelheid | ||
|style="background-color: white;"|100 gram | |style="background-color: white;"|100 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON | |style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar verstrekkingsverzoek | ||
|style="background-color: white;"|MBH_123_1_VV_1 | |style="background-color: white;"|MBH_123_1_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_123_1 | |style="background-color: white;"|MBH_123_1 | ||
|}<section end=MVE_XXX_Bourgonje /> | |}<section end=MVE_XXX_Bourgonje /> | ||
| Regel 1.005: | Regel 1.005: | ||
<section begin=MGB_XXX_Bourgonje /> | <section begin=MGB_XXX_Bourgonje /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_123_1_MGB_1 | |style="background-color: white;"|MBH_123_1_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|12 aug 2018, om 20:58 | |style="background-color: white;"|12 aug 2018, om 20:58 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 11 aug 2018, gedurende 2 dagen | |style="background-color: white;"|Vanaf 11 aug 2018, gedurende 2 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
|style="background-color: white;"|Aanbrengen (code = '1018') | |style="background-color: white;"|Aanbrengen (code = '1018') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|2 maal per dag | |style="background-color: white;"|2 maal per dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_123_1_MA_1 | |style="background-color: white;"|MBH_123_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_123_1 | |style="background-color: white;"|MBH_123_1 | ||
|}<section end=MGB_XXX_Bourgonje /> | |}<section end=MGB_XXX_Bourgonje /> | ||
==Patiënt J. XXX_Cnossen== | ==Patiënt J. XXX_Cnossen== | ||
<section begin=XXX_Cnossen /> | <section begin=XXX_Cnossen /> | ||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patient | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Naamgegevens | ||
|style="background-color: white;"|J. XXX_Cnossen | |style="background-color: white;"|J. XXX_Cnossen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Patient identificatienummer | ||
|style="background-color: white;"|999911740 [BSN] | |style="background-color: white;"|999911740 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Patient identificatienummer | ||
|style="background-color: white;"|31105 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | |style="background-color: white;"|31105 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geboortedatum | ||
|style="background-color: white;"|4 aug 1964 | |style="background-color: white;"|4 aug 1964 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geslacht | ||
|style="background-color: white;"|Man (code = 'M') | |style="background-color: white;"|Man (code = 'M') | ||
|}<section end=XXX_Cnossen /> | |}<section end=XXX_Cnossen /> | ||
| Regel 1.075: | Regel 1.075: | ||
<section begin=MA_XXX_Cnossen /> | <section begin=MA_XXX_Cnossen /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_313_1_MA_1 | |style="background-color: white;"|MBH_313_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|26 mei 2018, om 12:11 | |style="background-color: white;"|26 mei 2018, om 12:11 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 26 mei 2018, tot nader order | |style="background-color: white;"|Vanaf 26 mei 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Tiotropium inhalatiecapsule 18ug | |style="background-color: white;"|Tiotropium inhalatiecapsule 18ug (code = '59919') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | |style="background-color: white;"|Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Inhalatie (code = '62') | |style="background-color: white;"|Inhalatie (code = '62') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 dosis | |style="background-color: white;"|1 maal per dag 1 dosis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_313_1 | |style="background-color: white;"|MBH_313_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_313_1_MA_2 | |style="background-color: white;"|MBH_313_1_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|5 jul 2018, om 13:54 | |style="background-color: white;"|5 jul 2018, om 13:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 26 mei 2018, tot en met 6 jul 2018 23:59 | |style="background-color: white;"|Vanaf 26 mei 2018, tot en met 6 jul 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Stoptype | ||
|style="background-color: white;"|Staking | |style="background-color: white;"|Staking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Indicatie vervallen (code = '9') | |style="background-color: white;"|Indicatie vervallen (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Tiotropium inhalatiecapsule 18ug | |style="background-color: white;"|Tiotropium inhalatiecapsule 18ug (code = '59919') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 26 mei 2018 tot en met 6 jul 2018, 1 maal per dag 1 dosis, inhalatie | |style="background-color: white;"|Vanaf 26 mei 2018 tot en met 6 jul 2018, 1 maal per dag 1 dosis, inhalatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Inhalatie (code = '62') | |style="background-color: white;"|Inhalatie (code = '62') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 dosis | |style="background-color: white;"|1 maal per dag 1 dosis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_313_1 | |style="background-color: white;"|MBH_313_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_313_2_MA_1 | |style="background-color: white;"|MBH_313_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|21 apr 2017, om 10:19 | |style="background-color: white;"|21 apr 2017, om 10:19 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 21 apr 2017, tot nader order | |style="background-color: white;"|Vanaf 21 apr 2017, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml | |style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 21 apr 2017, tot nader order, 1x per dag 1 druppel, in beide ogen | |style="background-color: white;"|Vanaf 21 apr 2017, tot nader order, 1x per dag 1 druppel, in beide ogen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oculair (code = '7') | |style="background-color: white;"|Oculair (code = '7') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
|style="background-color: white;"|In beide ogen (code = '1026') | |style="background-color: white;"|In beide ogen (code = '1026') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 druppel | |style="background-color: white;"|1 maal per dag 1 druppel | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_313_2 | |style="background-color: white;"|MBH_313_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_313_2_MA_2 | |style="background-color: white;"|MBH_313_2_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|2 sep 2017, om 17:54 | |style="background-color: white;"|2 sep 2017, om 17:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 21 apr 2017, tot en met 2 sep 2017 17:00 | |style="background-color: white;"|Vanaf 21 apr 2017, tot en met 2 sep 2017 17:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Stoptype | ||
|style="background-color: white;"|Staking | |style="background-color: white;"|Staking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Indicatie vervallen (code = '9') | |style="background-color: white;"|Indicatie vervallen (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml | |style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 21 apr 2017 tot en met 2 sep 2017 17:00, 1x per dag 1 druppel, in beide ogen | |style="background-color: white;"|Vanaf 21 apr 2017 tot en met 2 sep 2017 17:00, 1x per dag 1 druppel, in beide ogen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oculair (code = '7') | |style="background-color: white;"|Oculair (code = '7') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
|style="background-color: white;"|In beide ogen (code = '1026') | |style="background-color: white;"|In beide ogen (code = '1026') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 druppel | |style="background-color: white;"|1 maal per dag 1 druppel | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_313_2 | |style="background-color: white;"|MBH_313_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_313_3_MA_1 | |style="background-color: white;"|MBH_313_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|26 mei 2018, om 12:11 | |style="background-color: white;"|26 mei 2018, om 12:11 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 26 mei 2018, tot nader order | |style="background-color: white;"|Vanaf 26 mei 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|CARBASALAATCALCIUM 100MG PO | |style="background-color: white;"|CARBASALAATCALCIUM 100MG PO (code = '13072') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_313_3 | |style="background-color: white;"|MBH_313_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_313_3_MA_2 | |style="background-color: white;"|MBH_313_3_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|30 aug 2018, om 13:54 | |style="background-color: white;"|30 aug 2018, om 13:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 26 mei 2018, tot en met 29 aug 2018 23:59 | |style="background-color: white;"|Vanaf 26 mei 2018, tot en met 29 aug 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Stoptype | ||
|style="background-color: white;"|Onderbreking | |style="background-color: white;"|Onderbreking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|CARBASALAATCALCIUM 100MG PO | |style="background-color: white;"|CARBASALAATCALCIUM 100MG PO (code = '13072') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 26 mei 2018 tot en met 29 aug 2018, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | |style="background-color: white;"|Vanaf 26 mei 2018 tot en met 29 aug 2018, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_313_3 | |style="background-color: white;"|MBH_313_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_313_4_MA_1 | |style="background-color: white;"|MBH_313_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|7 nov 2017, om 14:23 | |style="background-color: white;"|7 nov 2017, om 14:23 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 7 nov 2017, tot nader order | |style="background-color: white;"|Vanaf 7 nov 2017, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Omeprazol tablet MSR 40mg | |style="background-color: white;"|Omeprazol tablet MSR 40mg (code = '88803') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 7 nov 2017, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 7 nov 2017, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_313_4 | |style="background-color: white;"|MBH_313_4 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_313_4_MA_2 | |style="background-color: white;"|MBH_313_4_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|24 jan 2018, om 08:54 | |style="background-color: white;"|24 jan 2018, om 08:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 7 nov 2017, tot en met 23 jan 2018 23:59 | |style="background-color: white;"|Vanaf 7 nov 2017, tot en met 23 jan 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Stoptype | ||
|style="background-color: white;"|Onderbreking | |style="background-color: white;"|Onderbreking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Omeprazol tablet MSR 40mg | |style="background-color: white;"|Omeprazol tablet MSR 40mg (code = '88803') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 7 nov 2017 tot en met 23 jan 2018, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | |style="background-color: white;"|Vanaf 7 nov 2017 tot en met 23 jan 2018, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_313_4 | |style="background-color: white;"|MBH_313_4 | ||
|}<section end=MA_XXX_Cnossen /> | |}<section end=MA_XXX_Cnossen /> | ||
| Regel 1.417: | Regel 1.417: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_313_1_TA_1 | |style="background-color: white;"|MBH_313_1_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|26 mei 2018, om 12:11 | |style="background-color: white;"|26 mei 2018, om 12:11 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 26 mei 2018, tot nader order | |style="background-color: white;"|Vanaf 26 mei 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|SPIRIVA INHALPDR 18MCG | |style="background-color: white;"|SPIRIVA INHALPDR 18MCG (code = '1476866') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | |style="background-color: white;"|Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Inhalatie (code = '62') | |style="background-color: white;"|Inhalatie (code = '62') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 dosis | |style="background-color: white;"|1 maal per dag 1 dosis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_313_1_MA_1 | |style="background-color: white;"|MBH_313_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_313_1 | |style="background-color: white;"|MBH_313_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_313_1_TA_2 | |style="background-color: white;"|MBH_313_1_TA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|5 jul 2018, om 13:54 | |style="background-color: white;"|5 jul 2018, om 13:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 26 mei 2018, tot en met 6 jul 2018 23:59 | |style="background-color: white;"|Vanaf 26 mei 2018, tot en met 6 jul 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Stoptype | ||
|style="background-color: white;"|Staking | |style="background-color: white;"|Staking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|SPIRIVA INHALPDR 18MCG | |style="background-color: white;"|SPIRIVA INHALPDR 18MCG (code = '1476866') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 26 mei 2018 tot en met 6 jul 2018, 1 maal per dag 1 dosis, inhalatie | |style="background-color: white;"|Vanaf 26 mei 2018 tot en met 6 jul 2018, 1 maal per dag 1 dosis, inhalatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Inhalatie (code = '62') | |style="background-color: white;"|Inhalatie (code = '62') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 dosis | |style="background-color: white;"|1 maal per dag 1 dosis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_313_1_MA_2 | |style="background-color: white;"|MBH_313_1_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_313_1 | |style="background-color: white;"|MBH_313_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_313_2_TA_1 | |style="background-color: white;"|MBH_313_2_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|21 apr 2017, om 10:19 | |style="background-color: white;"|21 apr 2017, om 10:19 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 21 apr 2017, tot nader order | |style="background-color: white;"|Vanaf 21 apr 2017, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|LATANOPROST/TIMOLOL SDZ OOGDR 0,05/5MG/ML FL 2,5ML | |style="background-color: white;"|LATANOPROST/TIMOLOL SDZ OOGDR 0,05/5MG/ML FL 2,5ML (code = '2226294') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 21 apr 2017, tot nader order, 1x per dag 1 druppel, in beide ogen | |style="background-color: white;"|Vanaf 21 apr 2017, tot nader order, 1x per dag 1 druppel, in beide ogen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oculair (code = '7') | |style="background-color: white;"|Oculair (code = '7') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
|style="background-color: white;"|In beide ogen (code = '1026') | |style="background-color: white;"|In beide ogen (code = '1026') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 druppel | |style="background-color: white;"|1 maal per dag 1 druppel | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_313_2_MA_1 | |style="background-color: white;"|MBH_313_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_313_2 | |style="background-color: white;"|MBH_313_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_313_2_TA_2 | |style="background-color: white;"|MBH_313_2_TA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|2 sep 2017, om 17:54 | |style="background-color: white;"|2 sep 2017, om 17:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 21 apr 2017, tot en met 2 sep 2017 17:00 | |style="background-color: white;"|Vanaf 21 apr 2017, tot en met 2 sep 2017 17:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Stoptype | ||
|style="background-color: white;"|Staking | |style="background-color: white;"|Staking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|LATANOPROST/TIMOLOL SDZ OOGDR 0,05/5MG/ML FL 2,5ML | |style="background-color: white;"|LATANOPROST/TIMOLOL SDZ OOGDR 0,05/5MG/ML FL 2,5ML (code = '2226294') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 21 apr 2017 tot en met 2 sep 2017 17:00, 1x per dag 1 druppel, in beide ogen | |style="background-color: white;"|Vanaf 21 apr 2017 tot en met 2 sep 2017 17:00, 1x per dag 1 druppel, in beide ogen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oculair (code = '7') | |style="background-color: white;"|Oculair (code = '7') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
|style="background-color: white;"|In beide ogen (code = '1026') | |style="background-color: white;"|In beide ogen (code = '1026') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 druppel | |style="background-color: white;"|1 maal per dag 1 druppel | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_313_2_MA_2 | |style="background-color: white;"|MBH_313_2_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_313_2 | |style="background-color: white;"|MBH_313_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_313_3_TA_1 | |style="background-color: white;"|MBH_313_3_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|26 mei 2018, om 12:30 | |style="background-color: white;"|26 mei 2018, om 12:30 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 26 mei 2018, tot nader order | |style="background-color: white;"|Vanaf 26 mei 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|CARBASALAATCALCIUM CF SACHET 100MG | |style="background-color: white;"|CARBASALAATCALCIUM CF SACHET 100MG (code = '1113534') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_313_3_MA_1 | |style="background-color: white;"|MBH_313_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_313_3 | |style="background-color: white;"|MBH_313_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_313_3_TA_2 | |style="background-color: white;"|MBH_313_3_TA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|30 aug 2018, om 14:54 | |style="background-color: white;"|30 aug 2018, om 14:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 26 mei 2018, tot en met 29 aug 2018 23:59 | |style="background-color: white;"|Vanaf 26 mei 2018, tot en met 29 aug 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Stoptype | ||
|style="background-color: white;"|Onderbreking | |style="background-color: white;"|Onderbreking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|CARBASALAATCALCIUM CF SACHET 100MG | |style="background-color: white;"|CARBASALAATCALCIUM CF SACHET 100MG (code = '1113534') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 26 mei 2018 tot en met 29 aug 2018, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | |style="background-color: white;"|Vanaf 26 mei 2018 tot en met 29 aug 2018, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_313_3_MA_2 | |style="background-color: white;"|MBH_313_3_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_313_3 | |style="background-color: white;"|MBH_313_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_313_4_TA_1 | |style="background-color: white;"|MBH_313_4_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|7 nov 2017, om 15:23 | |style="background-color: white;"|7 nov 2017, om 15:23 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 7 nov 2017, tot nader order | |style="background-color: white;"|Vanaf 7 nov 2017, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|OMEPRAZOL SANDOZ MUT TABLET MSR 40MG | |style="background-color: white;"|OMEPRAZOL SANDOZ MUT TABLET MSR 40MG (code = '2124971') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 7 nov 2017, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 7 nov 2017, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_313_4_MA_1 | |style="background-color: white;"|MBH_313_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_313_4 | |style="background-color: white;"|MBH_313_4 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_313_4_TA_2 | |style="background-color: white;"|MBH_313_4_TA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|24 jan 2018, om 09:54 | |style="background-color: white;"|24 jan 2018, om 09:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 7 nov 2017, tot en met 23 jan 2018 23:59 | |style="background-color: white;"|Vanaf 7 nov 2017, tot en met 23 jan 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Stoptype | ||
|style="background-color: white;"|Onderbreking | |style="background-color: white;"|Onderbreking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|OMEPRAZOL SANDOZ MUT TABLET MSR 40MG | |style="background-color: white;"|OMEPRAZOL SANDOZ MUT TABLET MSR 40MG (code = '2124971') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 7 nov 2017 tot en met 23 jan 2018, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | |style="background-color: white;"|Vanaf 7 nov 2017 tot en met 23 jan 2018, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_313_4_MA_2 | |style="background-color: white;"|MBH_313_4_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_313_4 | |style="background-color: white;"|MBH_313_4 | ||
|} | |} | ||
| Regel 1.765: | Regel 1.765: | ||
<section begin=MGB_XXX_Cnossen /> | <section begin=MGB_XXX_Cnossen /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_313_1_MGB_1 | |style="background-color: white;"|MBH_313_1_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|6 jul 2018, om 12:11 | |style="background-color: white;"|6 jul 2018, om 12:11 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 6 jul 2018, tot nader order | |style="background-color: white;"|Vanaf 6 jul 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Tiotropium inhalatiecapsule 18ug | |style="background-color: white;"|Tiotropium inhalatiecapsule 18ug (code = '59919') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf T-100, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | |style="background-color: white;"|Vanaf T-100, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Inhalatie (code = '62') | |style="background-color: white;"|Inhalatie (code = '62') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 dosis | |style="background-color: white;"|1 maal per dag 1 dosis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_313_1_MA_1 | |style="background-color: white;"|MBH_313_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_313_1 | |style="background-color: white;"|MBH_313_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_313_1_MGB_2 | |style="background-color: white;"|MBH_313_1_MGB_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|18 jun 2018, om 15:25 | |style="background-color: white;"|18 jun 2018, om 15:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|False | |style="background-color: white;"|False | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 8 mei 2018, tot en met 18 jun 2018 23:59 | |style="background-color: white;"|Vanaf 8 mei 2018, tot en met 18 jun 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Stoptype | ||
|style="background-color: white;"|Staking | |style="background-color: white;"|Staking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Tiotropium inhalatiecapsule 18ug | |style="background-color: white;"|Tiotropium inhalatiecapsule 18ug (code = '59919') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf T-100, tot en met T-59, 1 maal per dag 1 dosis, inhalatie | |style="background-color: white;"|Vanaf T-100, tot en met T-59, 1 maal per dag 1 dosis, inhalatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Inhalatie (code = '62') | |style="background-color: white;"|Inhalatie (code = '62') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 dosis | |style="background-color: white;"|1 maal per dag 1 dosis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_313_1_MA_2 | |style="background-color: white;"|MBH_313_1_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_313_1 | |style="background-color: white;"|MBH_313_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_313_2_MGB_1 | |style="background-color: white;"|MBH_313_2_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|3 apr 2017, om 10:19 | |style="background-color: white;"|3 apr 2017, om 10:19 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 apr 2017, tot nader order | |style="background-color: white;"|Vanaf 3 apr 2017, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml | |style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf T-500, tot nader order, 1x per dag 1 druppel, in beide ogen | |style="background-color: white;"|Vanaf T-500, tot nader order, 1x per dag 1 druppel, in beide ogen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oculair (code = '7') | |style="background-color: white;"|Oculair (code = '7') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
|style="background-color: white;"|In beide ogen (code = '1026') | |style="background-color: white;"|In beide ogen (code = '1026') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 druppel | |style="background-color: white;"|1 maal per dag 1 druppel | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_313_2_MA_1 | |style="background-color: white;"|MBH_313_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_313_2 | |style="background-color: white;"|MBH_313_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_313_2_MGB_2 | |style="background-color: white;"|MBH_313_2_MGB_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|15 aug 2017, om 17:54 | |style="background-color: white;"|15 aug 2017, om 17:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 apr 2017, tot en met 15 aug 2017 17:00 | |style="background-color: white;"|Vanaf 3 apr 2017, tot en met 15 aug 2017 17:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Stoptype | ||
|style="background-color: white;"|Staking | |style="background-color: white;"|Staking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml | |style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf T-500, tot en met T-366 17:00, 1x per dag 1 druppel, in beide ogen | |style="background-color: white;"|Vanaf T-500, tot en met T-366 17:00, 1x per dag 1 druppel, in beide ogen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oculair (code = '7') | |style="background-color: white;"|Oculair (code = '7') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
|style="background-color: white;"|In beide ogen (code = '1026') | |style="background-color: white;"|In beide ogen (code = '1026') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 druppel | |style="background-color: white;"|1 maal per dag 1 druppel | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_313_2_MA_2 | |style="background-color: white;"|MBH_313_2_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_313_2 | |style="background-color: white;"|MBH_313_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_313_3_MGB_1 | |style="background-color: white;"|MBH_313_3_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|8 mei 2018, om 12:11 | |style="background-color: white;"|8 mei 2018, om 12:11 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 8 mei 2018, tot nader order | |style="background-color: white;"|Vanaf 8 mei 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|CARBASALAATCALCIUM 100MG PO | |style="background-color: white;"|CARBASALAATCALCIUM 100MG PO (code = '13072') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf T-100, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf T-100, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_313_3_MA_1 | |style="background-color: white;"|MBH_313_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_313_3 | |style="background-color: white;"|MBH_313_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_313_3_MGB_2 | |style="background-color: white;"|MBH_313_3_MGB_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|12 aug 2017, om 13:54 | |style="background-color: white;"|12 aug 2017, om 13:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 8 mei 2018, tot en met 11 aug 2018 23:59 | |style="background-color: white;"|Vanaf 8 mei 2018, tot en met 11 aug 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Stoptype | ||
|style="background-color: white;"|Onderbreking | |style="background-color: white;"|Onderbreking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|CARBASALAATCALCIUM 100MG PO | |style="background-color: white;"|CARBASALAATCALCIUM 100MG PO (code = '13072') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf T-100, tot en met T-5, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken vanaf T-4 | |style="background-color: white;"|Vanaf T-100, tot en met T-5, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken vanaf T-4 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_313_3_MA_2 | |style="background-color: white;"|MBH_313_3_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_313_3 | |style="background-color: white;"|MBH_313_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_313_4_MGB_1 | |style="background-color: white;"|MBH_313_4_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|20 okt 2017, om 14:23 | |style="background-color: white;"|20 okt 2017, om 14:23 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 20 okt 2017, tot nader order | |style="background-color: white;"|Vanaf 20 okt 2017, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Omeprazol tablet MSR 40mg | |style="background-color: white;"|Omeprazol tablet MSR 40mg (code = '88803') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf T-300, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf T-300, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_313_4_MA_1 | |style="background-color: white;"|MBH_313_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_313_4 | |style="background-color: white;"|MBH_313_4 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_313_4_MGB_2 | |style="background-color: white;"|MBH_313_4_MGB_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|6 jan 2018, om 08:54 | |style="background-color: white;"|6 jan 2018, om 08:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 20 okt 2017, tot en met 5 jan 2018 23:59 | |style="background-color: white;"|Vanaf 20 okt 2017, tot en met 5 jan 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Stoptype | ||
|style="background-color: white;"|Onderbreking | |style="background-color: white;"|Onderbreking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Omeprazol tablet MSR 40mg | |style="background-color: white;"|Omeprazol tablet MSR 40mg (code = '88803') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf T-300, tot en met T-223, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken vanaf T-222 | |style="background-color: white;"|Vanaf T-300, tot en met T-223, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken vanaf T-222 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_313_4_MA_2 | |style="background-color: white;"|MBH_313_4_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_313_4 | |style="background-color: white;"|MBH_313_4 | ||
|}<section end=MGB_XXX_Cnossen /> | |}<section end=MGB_XXX_Cnossen /> | ||
==Patiënt R. XXX_Dirksz== | ==Patiënt R. XXX_Dirksz== | ||
<section begin=XXX_Dirksz /> | <section begin=XXX_Dirksz /> | ||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patient | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Naamgegevens | ||
|style="background-color: white;"|R. XXX_Dirksz | |style="background-color: white;"|R. XXX_Dirksz | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Patient identificatienummer | ||
|style="background-color: white;"|999911326 [BSN] | |style="background-color: white;"|999911326 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Patient identificatienummer | ||
|style="background-color: white;"|11101 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | |style="background-color: white;"|11101 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geboortedatum | ||
|style="background-color: white;"|1 aug 1964 | |style="background-color: white;"|1 aug 1964 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geslacht | ||
|style="background-color: white;"|Man (code = 'M') | |style="background-color: white;"|Man (code = 'M') | ||
|}<section end=XXX_Dirksz /> | |}<section end=XXX_Dirksz /> | ||
| Regel 2.185: | Regel 2.185: | ||
<section begin=MA_XXX_Dirksz /> | <section begin=MA_XXX_Dirksz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_113_1_MA_1 | |style="background-color: white;"|MBH_113_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|15 jul 2018, om 11:25 | |style="background-color: white;"|15 jul 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Metoclopramide zetpil 20mg | |style="background-color: white;"|Metoclopramide zetpil 20mg (code = '6939') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen, zo nodig 1 maal per dag 1 stuk, rectaal | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen, zo nodig 1 maal per dag 1 stuk, rectaal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Rectaal (code = '12') | |style="background-color: white;"|Rectaal (code = '12') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk | |style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_113_1 | |style="background-color: white;"|MBH_113_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_113_2_MA_1 | |style="background-color: white;"|MBH_113_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|4 aug 2018, om 14:55 | |style="background-color: white;"|4 aug 2018, om 14:55 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken | |style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Zestril tabel 10mg | |style="background-color: white;"|Zestril tabel 10mg (code = '615560') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_113_2 | |style="background-color: white;"|MBH_113_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_113_3_MA_1 | |style="background-color: white;"|MBH_113_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|4 aug 2018, om 14:57 | |style="background-color: white;"|4 aug 2018, om 14:57 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 4 aug 2018, tot nader order | |style="background-color: white;"|Vanaf 4 aug 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 4 aug 2018, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 4 aug 2018, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_113_3 | |style="background-color: white;"|MBH_113_3 | ||
|}<section end=MA_XXX_Dirksz /> | |}<section end=MA_XXX_Dirksz /> | ||
| Regel 2.310: | Regel 2.310: | ||
<section begin=VV_XXX_Dirksz /> | <section begin=VV_XXX_Dirksz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_113_1_VV_1 | |style="background-color: white;"|MBH_113_1_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Datum | ||
|style="background-color: white;"|15 jul 2018, om 11:25 | |style="background-color: white;"|15 jul 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Te verstrekken hoeveelheid | ||
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Metoclopramide zetpil 20mg | |style="background-color: white;"|Metoclopramide zetpil 20mg (code = '6939') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Beoogd verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_113_1_MA_1 | |style="background-color: white;"|MBH_113_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_113_1 | |style="background-color: white;"|MBH_113_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_113_2_VV_1 | |style="background-color: white;"|MBH_113_2_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Datum | ||
|style="background-color: white;"|4 aug 2018, om 14:55 | |style="background-color: white;"|4 aug 2018, om 14:55 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Te verstrekken hoeveelheid | ||
|style="background-color: white;"|21 stuks | |style="background-color: white;"|21 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Zestril tabel 10mg | |style="background-color: white;"|Zestril tabel 10mg (code = '615560') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Beoogd verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_113_2_MA_1 | |style="background-color: white;"|MBH_113_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_113_2 | |style="background-color: white;"|MBH_113_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_113_3_VV_1 | |style="background-color: white;"|MBH_113_3_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Datum | ||
|style="background-color: white;"|4 aug 2018, om 14:57 | |style="background-color: white;"|4 aug 2018, om 14:57 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Te verstrekken hoeveelheid | ||
|style="background-color: white;"|21 stuks | |style="background-color: white;"|21 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Beoogd verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_113_3_MA_1 | |style="background-color: white;"|MBH_113_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_113_3 | |style="background-color: white;"|MBH_113_3 | ||
|}<section end=VV_XXX_Dirksz /> | |}<section end=VV_XXX_Dirksz /> | ||
| Regel 2.405: | Regel 2.405: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_113_1_TA_1 | |style="background-color: white;"|MBH_113_1_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|15 jul 2018, om 11:25 | |style="background-color: white;"|15 jul 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|PRIMPERAN ZETPIL 20MG | |style="background-color: white;"|PRIMPERAN ZETPIL 20MG (code = '229709') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen, zo nodig 1 maal per dag 1 stuk, rectaal | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen, zo nodig 1 maal per dag 1 stuk, rectaal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Rectaal (code = '12') | |style="background-color: white;"|Rectaal (code = '12') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk | |style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_113_1_MA_1 | |style="background-color: white;"|MBH_113_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_113_1 | |style="background-color: white;"|MBH_113_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_113_2_TA_1 | |style="background-color: white;"|MBH_113_2_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|4 aug 2018, om 14:55 | |style="background-color: white;"|4 aug 2018, om 14:55 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken | |style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Zestril tabel 10mg | |style="background-color: white;"|Zestril tabel 10mg (code = '615560') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_113_2_MA_1 | |style="background-color: white;"|MBH_113_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_113_2 | |style="background-color: white;"|MBH_113_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_113_3_TA_1 | |style="background-color: white;"|MBH_113_3_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|4 aug 2018, om 14:57 | |style="background-color: white;"|4 aug 2018, om 14:57 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 4 aug 2018, tot nader order | |style="background-color: white;"|Vanaf 4 aug 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|ROTER APC TABLET | |style="background-color: white;"|ROTER APC TABLET (code = '202185') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 4 aug 2018, tot nader order, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 4 aug 2018, tot nader order, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_113_2_MA_1 | |style="background-color: white;"|MBH_113_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_113_3 | |style="background-color: white;"|MBH_113_3 | ||
|} | |} | ||
| Regel 2.530: | Regel 2.530: | ||
<section begin=MVE_XXX_Dirksz /> | <section begin=MVE_XXX_Dirksz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_113_1_MVE_1 | |style="background-color: white;"|MBH_113_1_MVE_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Datum | ||
|style="background-color: white;"|15 jul 2018, om 12:25 | |style="background-color: white;"|15 jul 2018, om 12:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekte hoeveelheid | ||
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|PRIMPERAN ZETPIL 20MG | |style="background-color: white;"|PRIMPERAN ZETPIL 20MG (code = '229709') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar verstrekkingsverzoek | ||
|style="background-color: white;"|MBH_113_1_VV_1 | |style="background-color: white;"|MBH_113_1_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_113_1 | |style="background-color: white;"|MBH_113_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_113_2_MVE_1 | |style="background-color: white;"|MBH_113_2_MVE_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Datum | ||
|style="background-color: white;"|4 aug 2018, om 15:55 | |style="background-color: white;"|4 aug 2018, om 15:55 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekte hoeveelheid | ||
|style="background-color: white;"|25 stuks | |style="background-color: white;"|25 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Zestril tablet 10mg | |style="background-color: white;"|Zestril tablet 10mg (code = '615560') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar verstrekkingsverzoek | ||
|style="background-color: white;"|MBH_113_2_VV_1 | |style="background-color: white;"|MBH_113_2_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_113_2 | |style="background-color: white;"|MBH_113_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_113_3_MVE_1 | |style="background-color: white;"|MBH_113_3_MVE_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Datum | ||
|style="background-color: white;"|4 aug 2018, om 15:56 | |style="background-color: white;"|4 aug 2018, om 15:56 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekte hoeveelheid | ||
|style="background-color: white;"|21 stuks | |style="background-color: white;"|21 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|ROTER APC TABLET | |style="background-color: white;"|ROTER APC TABLET (code = '202185') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar verstrekkingsverzoek | ||
|style="background-color: white;"|MBH_113_3_VV_1 | |style="background-color: white;"|MBH_113_3_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_113_3 | |style="background-color: white;"|MBH_113_3 | ||
|}<section end=MVE_XXX_Dirksz /> | |}<section end=MVE_XXX_Dirksz /> | ||
| Regel 2.616: | Regel 2.616: | ||
<section begin=MGB_XXX_Dirksz /> | <section begin=MGB_XXX_Dirksz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_113_1_MGB_1 | |style="background-color: white;"|MBH_113_1_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|17 jul 2018, om 11:25 | |style="background-color: white;"|17 jul 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 17 jul 2018, gedurende 1 dag | |style="background-color: white;"|Vanaf 17 jul 2018, gedurende 1 dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Metoclopramide zetpil 20mg | |style="background-color: white;"|Metoclopramide zetpil 20mg (code = '6939') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 17 jul 2018, gedurende 1 dag, 1 maal per dag 1 stuk, rectaal | |style="background-color: white;"|Vanaf 17 jul 2018, gedurende 1 dag, 1 maal per dag 1 stuk, rectaal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Rectaal (code = '12') | |style="background-color: white;"|Rectaal (code = '12') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk | |style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_113_1_MA_1 | |style="background-color: white;"|MBH_113_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_113_1 | |style="background-color: white;"|MBH_113_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_113_2_MGB_1 | |style="background-color: white;"|MBH_113_2_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|21 aug 2018, om 14:55 | |style="background-color: white;"|21 aug 2018, om 14:55 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Volgens afspraak indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken | |style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Zestril tabel 10mg | |style="background-color: white;"|Zestril tabel 10mg (code = '615560') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 4 aug 2018, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_113_2_MA_1 | |style="background-color: white;"|MBH_113_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_113_2 | |style="background-color: white;"|MBH_113_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_113_3_MGB_1 | |style="background-color: white;"|MBH_113_3_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|5 aug 2018, om 14:57 | |style="background-color: white;"|5 aug 2018, om 14:57 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 5 aug 2018, tot en met 26 aug 2018 23:59 | |style="background-color: white;"|Vanaf 5 aug 2018, tot en met 26 aug 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 5 aug 2018 tot en met 26 aug 2018, 1 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 5 aug 2018 tot en met 26 aug 2018, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_113_3_MA_1 | |style="background-color: white;"|MBH_113_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_113_3 | |style="background-color: white;"|MBH_113_3 | ||
|}<section end=MGB_XXX_Dirksz /> | |}<section end=MGB_XXX_Dirksz /> | ||
==Patiënt R. XXX_Gobee== | ==Patiënt R. XXX_Gobee== | ||
<section begin=XXX_Gobee /> | <section begin=XXX_Gobee /> | ||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patient | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Naamgegevens | ||
|style="background-color: white;"|R. XXX_Gobee | |style="background-color: white;"|R. XXX_Gobee | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Patient identificatienummer | ||
|style="background-color: white;"|999911314 [BSN] | |style="background-color: white;"|999911314 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Patient identificatienummer | ||
|style="background-color: white;"|21104 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | |style="background-color: white;"|21104 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geboortedatum | ||
|style="background-color: white;"|1 aug 1964 | |style="background-color: white;"|1 aug 1964 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F') | |style="background-color: white;"|Vrouw (code = 'F') | ||
|}<section end=XXX_Gobee /> | |}<section end=XXX_Gobee /> | ||
| Regel 2.786: | Regel 2.786: | ||
<section begin=MA_XXX_Gobee /> | <section begin=MA_XXX_Gobee /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_213_1_MA_1 | |style="background-color: white;"|MBH_213_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|15 jul 2018, om 11:25 | |style="background-color: white;"|15 jul 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 15 jul 2018, tot nader order | |style="background-color: white;"|Vanaf 15 jul 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen, 1 à 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen, 1 à 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 à 2 maal per dag 1 stuk | |style="background-color: white;"|1 à 2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_213_1_MA_2 | |style="background-color: white;"|MBH_213_1_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|25 jul 2018, om 09:13 | |style="background-color: white;"|25 jul 2018, om 09:13 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 15 jul 2018, tot en met 24 jul 2018 23:59 | |style="background-color: white;"|Vanaf 15 jul 2018, tot en met 24 jul 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Stoptype | ||
|style="background-color: white;"|Staking | |style="background-color: white;"|Staking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar afspraak of gebruik: MA | ||
|style="background-color: white;"|MBH_213_1_MA_1 | |style="background-color: white;"|MBH_213_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 15 jul 2018 tot en met 24 jul 2018, 1 à 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 15 jul 2018 tot en met 24 jul 2018, 1 à 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 à 2 maal per dag 1 stuk | |style="background-color: white;"|1 à 2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_213_1_MA_3 | |style="background-color: white;"|MBH_213_1_MA_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|25 jul 2018, om 09:13 | |style="background-color: white;"|25 jul 2018, om 09:13 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 25 jul 2018, gedurende 30 dagen | |style="background-color: white;"|Vanaf 25 jul 2018, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar afspraak of gebruik: MA | ||
|style="background-color: white;"|MBH_213_1_MA_2 | |style="background-color: white;"|MBH_213_1_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Geen of onvoldoende effect (code = '5') | |style="background-color: white;"|Geen of onvoldoende effect (code = '5') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 25 jul 2018, gedurende 30 dagen, 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 25 jul 2018, gedurende 30 dagen, 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|2 maal per dag 1 stuk | |style="background-color: white;"|2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_213_1_MA_4 | |style="background-color: white;"|MBH_213_1_MA_4 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|19 aug 2018, om 09:13 | |style="background-color: white;"|19 aug 2018, om 09:13 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 25 jul 2018, tot en met 19 aug 2018 23:59 | |style="background-color: white;"|Vanaf 25 jul 2018, tot en met 19 aug 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Stoptype | ||
|style="background-color: white;"|Staking | |style="background-color: white;"|Staking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar afspraak of gebruik: MA | ||
|style="background-color: white;"|MBH_213_1_MA_3 | |style="background-color: white;"|MBH_213_1_MA_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 25 jul 2018 tot en met 19 aug 2018, 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 25 jul 2018 tot en met 19 aug 2018, 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|2 maal per dag 1 stuk | |style="background-color: white;"|2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_213_1_MA_5 | |style="background-color: white;"|MBH_213_1_MA_5 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|20 aug 2018, om 16:25 | |style="background-color: white;"|20 aug 2018, om 16:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 20 aug 2018, gedurende 30 dagen | |style="background-color: white;"|Vanaf 20 aug 2018, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar afspraak of gebruik: MA | ||
|style="background-color: white;"|MBH_213_1_MA_4 | |style="background-color: white;"|MBH_213_1_MA_4 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Wens patiënt (code = '12') | |style="background-color: white;"|Wens patiënt (code = '12') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 20 aug 2018, gedurende 30 dagen, 1 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 20 aug 2018, gedurende 30 dagen, 1 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|}<section end=MA_XXX_Gobee /> | |}<section end=MA_XXX_Gobee /> | ||
| Regel 3.005: | Regel 3.005: | ||
<section begin=VV_XXX_Gobee /> | <section begin=VV_XXX_Gobee /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_213_1_VV_1 | |style="background-color: white;"|MBH_213_1_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Datum | ||
|style="background-color: white;"|15 jul 2018, om 11:25 | |style="background-color: white;"|15 jul 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Te verstrekken hoeveelheid | ||
|style="background-color: white;"|40 stuks | |style="background-color: white;"|40 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Aantal herhalingen | ||
|style="background-color: white;"|1 | |style="background-color: white;"|1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Beoogd verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_213_1_MA_1 | |style="background-color: white;"|MBH_213_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_213_1_VV_2 | |style="background-color: white;"|MBH_213_1_VV_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Datum | ||
|style="background-color: white;"|25 jul 2018, om 09:13 | |style="background-color: white;"|25 jul 2018, om 09:13 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Te verstrekken hoeveelheid | ||
|style="background-color: white;"|60 stuks | |style="background-color: white;"|60 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Aantal herhalingen | ||
|style="background-color: white;"|1 | |style="background-color: white;"|1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Beoogd verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_213_1_MA_3 | |style="background-color: white;"|MBH_213_1_MA_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_213_1_VV_3 | |style="background-color: white;"|MBH_213_1_VV_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Datum | ||
|style="background-color: white;"|19 aug 2018, om 16:25 | |style="background-color: white;"|19 aug 2018, om 16:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verbruiksperiode | ||
|style="background-color: white;"|Vanaf 1 aug 2018, gedurende 30 dagen | |style="background-color: white;"|Vanaf 1 aug 2018, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Beoogd verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_213_1_MA_5 | |style="background-color: white;"|MBH_213_1_MA_5 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|}<section end=VV_XXX_Gobee /> | |}<section end=VV_XXX_Gobee /> | ||
| Regel 3.106: | Regel 3.106: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_213_1_TA_1 | |style="background-color: white;"|MBH_213_1_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|15 jul 2018, om 11:25 | |style="background-color: white;"|15 jul 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 15 jul 2018, tot nader order | |style="background-color: white;"|Vanaf 15 jul 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen, 1 à 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 30 dagen, 1 à 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 à 2 maal per dag 1 stuk | |style="background-color: white;"|1 à 2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_213_1_MA_1 | |style="background-color: white;"|MBH_213_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_213_1_TA_2 | |style="background-color: white;"|MBH_213_1_TA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|25 jul 2018, om 09:13 | |style="background-color: white;"|25 jul 2018, om 09:13 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 15 jul 2018, tot en met 24 jul 2018 23:59 | |style="background-color: white;"|Vanaf 15 jul 2018, tot en met 24 jul 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Stoptype | ||
|style="background-color: white;"|Staking | |style="background-color: white;"|Staking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 15 jul 2018 tot en met 24 jul 2018, 1 à 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 15 jul 2018 tot en met 24 jul 2018, 1 à 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 à 2 maal per dag 1 stuk | |style="background-color: white;"|1 à 2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_213_1_MA_2 | |style="background-color: white;"|MBH_213_1_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_213_1_TA_3 | |style="background-color: white;"|MBH_213_1_TA_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|25 jul 2018, om 09:13 | |style="background-color: white;"|25 jul 2018, om 09:13 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 25 jul 2018, gedurende 30 dagen | |style="background-color: white;"|Vanaf 25 jul 2018, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 25 jul 2018, gedurende 30 dagen, 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 25 jul 2018, gedurende 30 dagen, 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|2 maal per dag 1 stuk | |style="background-color: white;"|2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_213_1_MA_3 | |style="background-color: white;"|MBH_213_1_MA_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_213_1_TA_4 | |style="background-color: white;"|MBH_213_1_TA_4 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|19 aug 2018, om 09:13 | |style="background-color: white;"|19 aug 2018, om 09:13 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 25 jul 2018, tot en met 19 aug 2018 23:59 | |style="background-color: white;"|Vanaf 25 jul 2018, tot en met 19 aug 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Stoptype | ||
|style="background-color: white;"|Staking | |style="background-color: white;"|Staking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 25 jul 2018 tot en met 19 aug 2018, 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 25 jul 2018 tot en met 19 aug 2018, 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|2 maal per dag 1 stuk | |style="background-color: white;"|2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_213_1_MA_4 | |style="background-color: white;"|MBH_213_1_MA_4 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_213_1_TA_5 | |style="background-color: white;"|MBH_213_1_TA_5 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|19 aug 2018, om 16:25 | |style="background-color: white;"|19 aug 2018, om 16:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 20 aug 2018, gedurende 30 dagen | |style="background-color: white;"|Vanaf 20 aug 2018, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 20 aug 2018, gedurende 30 dagen, 1 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 20 aug 2018, gedurende 30 dagen, 1 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_213_1_MA_5 | |style="background-color: white;"|MBH_213_1_MA_5 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
| Regel 3.319: | Regel 3.319: | ||
<section begin=MVE_XXX_Gobee /> | <section begin=MVE_XXX_Gobee /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_213_1_MVE_1 | |style="background-color: white;"|MBH_213_1_MVE_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Datum | ||
|style="background-color: white;"|15 jul 2018, om 13:25 | |style="background-color: white;"|15 jul 2018, om 13:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekte hoeveelheid | ||
|style="background-color: white;"|40 stuks | |style="background-color: white;"|40 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar verstrekkingsverzoek | ||
|style="background-color: white;"|MBH_213_1_VV_1 | |style="background-color: white;"|MBH_213_1_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_213_1_MVE_2 | |style="background-color: white;"|MBH_213_1_MVE_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Datum | ||
|style="background-color: white;"|25 jul 2018, om 09:13 | |style="background-color: white;"|25 jul 2018, om 09:13 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekte hoeveelheid | ||
|style="background-color: white;"|60 stuks | |style="background-color: white;"|60 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar verstrekkingsverzoek | ||
|style="background-color: white;"|MBH_213_1_VV_2 | |style="background-color: white;"|MBH_213_1_VV_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_213_1_MVE_3 | |style="background-color: white;"|MBH_213_1_MVE_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Datum | ||
|style="background-color: white;"|19 aug 2018, om 17:25 | |style="background-color: white;"|19 aug 2018, om 17:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekte hoeveelheid | ||
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verbruiksduur | ||
|style="background-color: white;"|30 dagen | |style="background-color: white;"|30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar verstrekkingsverzoek | ||
|style="background-color: white;"|MBH_213_1_VV_2 | |style="background-color: white;"|MBH_213_1_VV_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|}<section end=MVE_XXX_Gobee /> | |}<section end=MVE_XXX_Gobee /> | ||
| Regel 3.408: | Regel 3.408: | ||
<section begin=MGB_XXX_Gobee /> | <section begin=MGB_XXX_Gobee /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_213_1_MGB_1 | |style="background-color: white;"|MBH_213_1_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|18 jul 2018, om 11:25 | |style="background-color: white;"|18 jul 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 15 jul 2018, gedurende 3 dagen | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 3 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 15 jul 2018, gedurende 3 dagen, 1 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 3 dagen, 1 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_213_1_MA_1 | |style="background-color: white;"|MBH_213_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_213_1_MGB_2 | |style="background-color: white;"|MBH_213_1_MGB_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|24 jul 2018, om 11:25 | |style="background-color: white;"|24 jul 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 19 jul 2018, gedurende 6 dagen | |style="background-color: white;"|Vanaf 19 jul 2018, gedurende 6 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 19 jul 2018, gedurende 6 dagen, 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 19 jul 2018, gedurende 6 dagen, 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|2 maal per dag 1 stuk | |style="background-color: white;"|2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_213_1_MA_1 | |style="background-color: white;"|MBH_213_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_213_1_MGB_3 | |style="background-color: white;"|MBH_213_1_MGB_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|30 jul 2018, om 19:25 | |style="background-color: white;"|30 jul 2018, om 19:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 25 jul 2018, gedurende 6 dagen | |style="background-color: white;"|Vanaf 25 jul 2018, gedurende 6 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 25 jul 2018, gedurende 6 dagen, 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 25 jul 2018, gedurende 6 dagen, 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|2 maal per dag 1 stuk | |style="background-color: white;"|2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: TA | ||
|style="background-color: white;"|MBH_213_1_TA_3 | |style="background-color: white;"|MBH_213_1_TA_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_213_1_MGB_4 | |style="background-color: white;"|MBH_213_1_MGB_4 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|18 aug 2018, om 11:25 | |style="background-color: white;"|18 aug 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 31 jul 2018, gedurende 19 dagen | |style="background-color: white;"|Vanaf 31 jul 2018, gedurende 19 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 31 jul 2018, gedurende 19 dagen, 2 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 31 jul 2018, gedurende 19 dagen, 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|2 maal per dag 1 stuk | |style="background-color: white;"|2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_213_1_MA_3 | |style="background-color: white;"|MBH_213_1_MA_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_213_1_MGB_5 | |style="background-color: white;"|MBH_213_1_MGB_5 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|24 aug 2018, om 11:25 | |style="background-color: white;"|24 aug 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 20 aug 2018, gedurende 5 dagen | |style="background-color: white;"|Vanaf 20 aug 2018, gedurende 5 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 20 aug 2018, gedurende 5 dagen, 1 maal per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 20 aug 2018, gedurende 5 dagen, 1 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_213_1_MA_5 | |style="background-color: white;"|MBH_213_1_MA_5 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_213_1 | |style="background-color: white;"|MBH_213_1 | ||
|}<section end=MGB_XXX_Gobee /> | |}<section end=MGB_XXX_Gobee /> | ||
==Patiënt J. XXX_Kilkenny== | ==Patiënt J. XXX_Kilkenny== | ||
<section begin=XXX_Kilkenny /> | <section begin=XXX_Kilkenny /> | ||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patient | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Naamgegevens | ||
|style="background-color: white;"|J. XXX_Kilkenny | |style="background-color: white;"|J. XXX_Kilkenny | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Patient identificatienummer | ||
|style="background-color: white;"|999911752 [BSN] | |style="background-color: white;"|999911752 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Patient identificatienummer | ||
|style="background-color: white;"|22108 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | |style="background-color: white;"|22108 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geboortedatum | ||
|style="background-color: white;"|5 aug 1964 | |style="background-color: white;"|5 aug 1964 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F') | |style="background-color: white;"|Vrouw (code = 'F') | ||
|}<section end=XXX_Kilkenny /> | |}<section end=XXX_Kilkenny /> | ||
| Regel 3.666: | Regel 3.666: | ||
<section begin=MA_XXX_Kilkenny /> | <section begin=MA_XXX_Kilkenny /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_323_1_MA_1 | |style="background-color: white;"|MBH_323_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|29 aug 2018, om 15:34 | |style="background-color: white;"|29 aug 2018, om 15:34 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 14 aug 2018, tot en met 28 aug 2018 23:59 | |style="background-color: white;"|Vanaf 14 aug 2018, tot en met 28 aug 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Stoptype | ||
|style="background-color: white;"|Staking | |style="background-color: white;"|Staking | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|ADVIL BRUIS BRUISTABLET 400MG CITRUSSMAAK | |style="background-color: white;"|ADVIL BRUIS BRUISTABLET 400MG CITRUSSMAAK (code = '2121522') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 14 aug 2018 tot en met 28 aug 2018, 3x per dag 1 tablet | |style="background-color: white;"|Vanaf 14 aug 2018 tot en met 28 aug 2018, 3x per dag 1 tablet | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|3 maal per dag 1 stuk | |style="background-color: white;"|3 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_323_1 | |style="background-color: white;"|MBH_323_1 | ||
|}<section end=MA_XXX_Kilkenny /> | |}<section end=MA_XXX_Kilkenny /> | ||
| Regel 3.709: | Regel 3.709: | ||
<section begin=MGB_XXX_Kilkenny /> | <section begin=MGB_XXX_Kilkenny /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_323_1_MGB_1 | |style="background-color: white;"|MBH_323_1_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|24 aug 2018, om 11:25 | |style="background-color: white;"|24 aug 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 14 aug 2018, tot nader order | |style="background-color: white;"|Vanaf 14 aug 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|ADVIL BRUIS BRUISTABLET 400MG CITRUSSMAAK | |style="background-color: white;"|ADVIL BRUIS BRUISTABLET 400MG CITRUSSMAAK (code = '2121522') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 14 aug 2018, 3x per dag 1 tablet, oraal | |style="background-color: white;"|Vanaf 14 aug 2018, 3x per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|3 maal per dag 1 stuk | |style="background-color: white;"|3 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_323_1 | |style="background-color: white;"|MBH_323_1 | ||
|}<section end=MGB_XXX_Kilkenny /> | |}<section end=MGB_XXX_Kilkenny /> | ||
==Patiënt R. XXX_Ruys== | ==Patiënt R. XXX_Ruys== | ||
<section begin=XXX_Ruys /> | <section begin=XXX_Ruys /> | ||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patient | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Naamgegevens | ||
|style="background-color: white;"|R. XXX_Ruys | |style="background-color: white;"|R. XXX_Ruys | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Patient identificatienummer | ||
|style="background-color: white;"|999911351 [BSN] | |style="background-color: white;"|999911351 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Patient identificatienummer | ||
|style="background-color: white;"|13103 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | |style="background-color: white;"|13103 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geboortedatum | ||
|style="background-color: white;"|1 aug 1964 | |style="background-color: white;"|1 aug 1964 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geslacht | ||
|style="background-color: white;"|Man (code = 'M') | |style="background-color: white;"|Man (code = 'M') | ||
|}<section end=XXX_Ruys /> | |}<section end=XXX_Ruys /> | ||
==Patiënt R. XXX_Strengersz== | ==Patiënt R. XXX_Strengersz== | ||
<section begin=XXX_Strengersz /> | <section begin=XXX_Strengersz /> | ||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patient | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Naamgegevens | ||
|style="background-color: white;"|R. XXX_Strengersz | |style="background-color: white;"|R. XXX_Strengersz | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Patient identificatienummer | ||
|style="background-color: white;"|999911338 [BSN] | |style="background-color: white;"|999911338 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Patient identificatienummer | ||
|style="background-color: white;"|41106 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | |style="background-color: white;"|41106 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geboortedatum | ||
|style="background-color: white;"|1 aug 1964 | |style="background-color: white;"|1 aug 1964 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F') | |style="background-color: white;"|Vrouw (code = 'F') | ||
|}<section end=XXX_Strengersz /> | |}<section end=XXX_Strengersz /> | ||
| Regel 3.800: | Regel 3.800: | ||
<section begin=MA_XXX_Strengersz /> | <section begin=MA_XXX_Strengersz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_1_MA_1 | |style="background-color: white;"|MBH_413_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|3 sep 2018, om 11:25 | |style="background-color: white;"|3 sep 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 à 2 maal per dag 1 stuk | |style="background-color: white;"|1 à 2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_1 | |style="background-color: white;"|MBH_413_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_2_MA_1 | |style="background-color: white;"|MBH_413_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|3 sep 2018, om 11:25 | |style="background-color: white;"|3 sep 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, exact iedere 3 uur 16 IE, subcutaan | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, exact iedere 3 uur 16 IE, subcutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Subcutaan (code = '21') | |style="background-color: white;"|Subcutaan (code = '21') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|Exact iedere 3 uur 16 internationale eenheid | |style="background-color: white;"|Exact iedere 3 uur 16 internationale eenheid | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_2 | |style="background-color: white;"|MBH_413_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_3_MA_1 | |style="background-color: white;"|MBH_413_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|15 jul 2018, om 11:25 | |style="background-color: white;"|15 jul 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|3 maal per dag 1 à 2 stuks | |style="background-color: white;"|3 maal per dag 1 à 2 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_3 | |style="background-color: white;"|MBH_413_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_4_MA_1 | |style="background-color: white;"|MBH_413_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|14 aug 2018, om 10:26 | |style="background-color: white;"|14 aug 2018, om 10:26 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen, 3 maal per dag aanbrengen, cutaan | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen, 3 maal per dag aanbrengen, cutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Cutaan (code = '7') | |style="background-color: white;"|Cutaan (code = '7') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
|style="background-color: white;"|Aanbrengen (code = '1018') | |style="background-color: white;"|Aanbrengen (code = '1018') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|3 maal per dag | |style="background-color: white;"|3 maal per dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_4 | |style="background-color: white;"|MBH_413_4 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_5_MA_1 | |style="background-color: white;"|MBH_413_5_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|14 aug 2018, om 10:46 | |style="background-color: white;"|14 aug 2018, om 10:46 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Ibuprofen PCH tablet 600mg | |style="background-color: white;"|Ibuprofen PCH tablet 600mg (code = '641898') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen, 2 maal per dag ¼ tablet | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen, 2 maal per dag ¼ tablet | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|2 maal per dag 0.25 stuk | |style="background-color: white;"|2 maal per dag 0.25 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_5 | |style="background-color: white;"|MBH_413_5 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_6_MA_1 | |style="background-color: white;"|MBH_413_6_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Waterstofperoxide 30MG/ML | |style="background-color: white;"|Waterstofperoxide 30MG/ML (code = '67016') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="6"| | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Niet van toepassing (code = '1') | |style="background-color: white;"|Niet van toepassing (code = '1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
|style="background-color: white;"|Eerst oplossen in water (code = '27') | |style="background-color: white;"|Eerst oplossen in water (code = '27') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
|style="background-color: white;"|Mond spoelen, daarna uitspugen (code = '69') | |style="background-color: white;"|Mond spoelen, daarna uitspugen (code = '69') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|2 maal per dag 10 à 15 ml | |style="background-color: white;"|2 maal per dag 10 à 15 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_6 | |style="background-color: white;"|MBH_413_6 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_7_MA_1 | |style="background-color: white;"|MBH_413_7_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen, elke dag om 08:00, 14:00 en 20:00 uur 16IE | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen, elke dag om 08:00, 14:00 en 20:00 uur 16IE | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Subcutaan (code = '21') | |style="background-color: white;"|Subcutaan (code = '21') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|Elke dag om 08:00, 14:00 en 20:00 16 internationale eenheid | |style="background-color: white;"|Elke dag om 08:00, 14:00 en 20:00 16 internationale eenheid | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_7 | |style="background-color: white;"|MBH_413_7 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_8_MA_1 | |style="background-color: white;"|MBH_413_8_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|IMIQUIMOD 50MG/G CREME | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="6"| | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Subcutaan (code = '21') | |style="background-color: white;"|Subcutaan (code = '21') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
|style="background-color: white;"|Voor de nacht (code = '1128') | |style="background-color: white;"|Voor de nacht (code = '1128') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
|style="background-color: white;"|Aanbrengen (code = '1018') | |style="background-color: white;"|Aanbrengen (code = '1018') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|Op maandag, woensdag en vrijdag | |style="background-color: white;"|Op maandag, woensdag en vrijdag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_8 | |style="background-color: white;"|MBH_413_8 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_9_MA_1 | |style="background-color: white;"|MBH_413_9_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, 1 maal daags 1 stuk ’s avonds innemen, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, 1 maal daags 1 stuk ’s avonds innemen, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk 's avonds | |style="background-color: white;"|1 maal per dag 1 stuk 's avonds | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_9 | |style="background-color: white;"|MBH_413_9 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_10_MA_1 | |style="background-color: white;"|MBH_413_10_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Ethinyl estradiol/desogestrel tablet 30/150ug (Marvelon) | |style="background-color: white;"|Ethinyl estradiol/desogestrel tablet 30/150ug (Marvelon) (code = '16292') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|Gedurende 21 dagen 1 maal per dag 1 stuk | |style="background-color: white;"|Gedurende 21 dagen 1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Herhaalperiode cyclisch schema | ||
|style="background-color: white;"|28 dagen | |style="background-color: white;"|28 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_10 | |style="background-color: white;"|MBH_413_10 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_11_MA_1 | |style="background-color: white;"|MBH_413_11_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Fusidinezuur creme 20mg/g | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Cutaan (code = '7') | |style="background-color: white;"|Cutaan (code = '7') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
|style="background-color: white;"|Dun aanbrengen (code = '1033') | |style="background-color: white;"|Dun aanbrengen (code = '1033') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie 1 | |colspan="2"|Doseerinstructie 1 | ||
|style="background-color: white;"|Eerst gedurende 2 weken 1 maal per dag 3 gram | |style="background-color: white;"|Eerst gedurende 2 weken 1 maal per dag 3 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie 2 | |colspan="2"|Doseerinstructie 2 | ||
|style="background-color: white;"|Dan gedurende 3 weken 1 maal per dag 2 gram | |style="background-color: white;"|Dan gedurende 3 weken 1 maal per dag 2 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie 3 | |colspan="2"|Doseerinstructie 3 | ||
|style="background-color: white;"|Dan gedurende 6 dagen 1 maal per dag 1 gram | |style="background-color: white;"|Dan gedurende 6 dagen 1 maal per dag 1 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_11 | |style="background-color: white;"|MBH_413_11 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_12_MA_1 | |style="background-color: white;"|MBH_413_12_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|3 sep 2018, om 11:25 | |style="background-color: white;"|3 sep 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|Bij hoest 3 à 4 maal per uur 1 stuk | |style="background-color: white;"|Bij hoest 3 à 4 maal per uur 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_12 | |style="background-color: white;"|MBH_413_12 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_13_MA_1 | |style="background-color: white;"|MBH_413_13_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|6 aug 2018, om 09:12 | |style="background-color: white;"|6 aug 2018, om 09:12 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 6 aug 2018, gedurende 8 dagen | |style="background-color: white;"|Vanaf 6 aug 2018, gedurende 8 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 6 aug 2018, gedurende 8 dagen, 0.5 ml per uur parenteraal | |style="background-color: white;"|Vanaf 6 aug 2018, gedurende 8 dagen, 0.5 ml per uur parenteraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Parenteraal (code = '10') | |style="background-color: white;"|Parenteraal (code = '10') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|0.5 ml per uur | |style="background-color: white;"|0.5 ml per uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_13 | |style="background-color: white;"|MBH_413_13 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_13_MA_2 | |style="background-color: white;"|MBH_413_13_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|14 aug 2018, om 11:25 | |style="background-color: white;"|14 aug 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 14 aug 2018, gedurende 8 dagen | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 8 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 14 aug 2018, gedurende 8 dagen, 0.2 tot 0.5 ml per uur parenteraal | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 8 dagen, 0.2 tot 0.5 ml per uur parenteraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Parenteraal (code = '10') | |style="background-color: white;"|Parenteraal (code = '10') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|0.2 à 0.5 ml per uur | |style="background-color: white;"|0.2 à 0.5 ml per uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_13 | |style="background-color: white;"|MBH_413_13 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_14_MA_1 | |style="background-color: white;"|MBH_413_14_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|3 sep 2018, om 11:25 | |style="background-color: white;"|3 sep 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Tot nader order | |style="background-color: white;"|Tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister), transdermaal | |style="background-color: white;"|Tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister), transdermaal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Transdermaal (code = '58') | |style="background-color: white;"|Transdermaal (code = '58') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur | |style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_14 | |style="background-color: white;"|MBH_413_14 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_15_MA_1 | |style="background-color: white;"|MBH_413_15_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 4 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 4 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Reden afspraak | ||
|style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - Product specificatie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |rowspan="16"| | ||
|style="background-color: white;"| | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Product naam | |||
|style="background-color: white;"|Haparine 100 ie= 10 ml | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Omschrijving | |||
|style="background-color: white;"|Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Farmaceutische vorm | |||
|style="background-color: white;"|Vloeistof (code = '434') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingredient | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
||Ingredient code | |||
|style="background-color: white;"|Heparinum natricum (code = '898724') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
||Sterkte | |||
|style="background-color: white;"|100 internationale eenheid per 10 ml | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksinstructie | |colspan="3"|Ingredient | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
||Ingredient code | |||
|style="background-color: white;"|WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
||Sterkte | |||
|style="background-color: white;"|1 stuk per 10 ml | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingredient | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
||Ingredient code | |||
|style="background-color: white;"|NATRII CHLORIDUM (code = '256390') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
||Sterkte | |||
|style="background-color: white;"|0.09 gram per 10 ml | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 4 dagen, 2 maal per dag 10 ml, parenteraal | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 4 dagen, 2 maal per dag 10 ml, parenteraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Parenteraal (code = '10') | |style="background-color: white;"|Parenteraal (code = '10') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|2 maal per dag 10 ml | |style="background-color: white;"|2 maal per dag 10 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_15 | |style="background-color: white;"|MBH_413_15 | ||
|}<section end=MA_XXX_Strengersz /> | |}<section end=MA_XXX_Strengersz /> | ||
| Regel 4.485: | Regel 4.525: | ||
<section begin=VV_XXX_Strengersz /> | <section begin=VV_XXX_Strengersz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_15_VV_1 | |style="background-color: white;"|MBH_413_15_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Datum | ||
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Te verstrekken hoeveelheid | ||
|style="background-color: white;"|100 ml | |style="background-color: white;"|100 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Aantal herhalingen | ||
|style="background-color: white;"|1 | |style="background-color: white;"|1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - Product specificatie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |rowspan="16"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|Product naam | ||
|style="background-color: white;"| | |style="background-color: white;"|Haparine 100 ie= 10 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|Omschrijving | ||
|style="background-color: white;"| | |style="background-color: white;"|Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|Farmaceutische vorm | ||
|style="background-color: white;"| | |style="background-color: white;"|Vloeistof (code = '434') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingredient | |||
|style=" | |||
|colspan=" | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | ||Ingredient code | ||
|style="background-color: white;"|Heparinum natricum (code = '898724') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
||Sterkte | |||
|style="background-color: white;"|100 internationale eenheid per 10 ml | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingredient | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
||Ingredient code | |||
|style="background-color: white;"|WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
||Sterkte | |||
|style="background-color: white;"|1 stuk per 10 ml | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingredient | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
||Ingredient code | |||
|style="background-color: white;"|NATRII CHLORIDUM (code = '256390') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
||Sterkte | |||
|style="background-color: white;"|0.09 gram per 10 ml | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Beoogd verstrekker | |||
|style="background-color: white;"|Apotheek De Gulle Gaper | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Relatie naar medicatieafspraak | |||
|style="background-color: white;"|MBH_413_15_MA_1 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|MBH identificatie | |||
|style="background-color: white;"|MBH_413_15 | |||
|}<section end=VV_XXX_Strengersz /> | |||
===Toedieningsafspraken XXX_Strengersz === | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="3" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_413_1_TA_1 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Afspraakdatum | |||
|style="background-color: white;"|3 sep 2018, om 11:25 | |style="background-color: white;"|3 sep 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 à 2 maal per dag 1 stuk | |style="background-color: white;"|1 à 2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_413_1_MA_1 | |style="background-color: white;"|MBH_413_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_1 | |style="background-color: white;"|MBH_413_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_2_TA_1 | |style="background-color: white;"|MBH_413_2_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|3 sep 2018, om 11:25 | |style="background-color: white;"|3 sep 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|HUMULINE NPH INJ 100IE/ML PATROON 3ML | |style="background-color: white;"|HUMULINE NPH INJ 100IE/ML PATROON 3ML (code = '870471') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, exact iedere 3 uur 16 IE, subcutaan | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, exact iedere 3 uur 16 IE, subcutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Subcutaan (code = '21') | |style="background-color: white;"|Subcutaan (code = '21') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|Exact iedere 3 uur 16 internationale eenheid | |style="background-color: white;"|Exact iedere 3 uur 16 internationale eenheid | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_413_2_MA_1 | |style="background-color: white;"|MBH_413_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_2 | |style="background-color: white;"|MBH_413_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_3_TA_1 | |style="background-color: white;"|MBH_413_3_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|15 jul 2018, om 11:25 | |style="background-color: white;"|15 jul 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|3 maal per dag 1 à 2 stuks | |style="background-color: white;"|3 maal per dag 1 à 2 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_413_3_MA_1 | |style="background-color: white;"|MBH_413_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_3 | |style="background-color: white;"|MBH_413_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_4_TA_1 | |style="background-color: white;"|MBH_413_4_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|14 aug 2018, om 10:26 | |style="background-color: white;"|14 aug 2018, om 10:26 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON | |style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen, 3 maal per dag aanbrengen, cutaan | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen, 3 maal per dag aanbrengen, cutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Cutaan (code = '7') | |style="background-color: white;"|Cutaan (code = '7') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
|style="background-color: white;"|Aanbrengen (code = '1018') | |style="background-color: white;"|Aanbrengen (code = '1018') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|3 maal per dag | |style="background-color: white;"|3 maal per dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_413_4_MA_1 | |style="background-color: white;"|MBH_413_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_4 | |style="background-color: white;"|MBH_413_4 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_5_TA_1 | |style="background-color: white;"|MBH_413_5_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|14 aug 2018, om 10:46 | |style="background-color: white;"|14 aug 2018, om 10:46 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Ibuprofen PCH tablet 600mg | |style="background-color: white;"|Ibuprofen PCH tablet 600mg (code = '641898') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen, 2 maal per dag ¼ tablet, oraal | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen, 2 maal per dag ¼ tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|2 maal per dag 0.25 stuk | |style="background-color: white;"|2 maal per dag 0.25 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_413_5_MA_1 | |style="background-color: white;"|MBH_413_5_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_5 | |style="background-color: white;"|MBH_413_5 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_6_TA_1 | |style="background-color: white;"|MBH_413_6_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|SOLUTIO HYDROGENII PEROXIDI 3% M/V | |style="background-color: white;"|SOLUTIO HYDROGENII PEROXIDI 3% M/V (code = '603694') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="6"| | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Niet van toepassing (code = '1') | |style="background-color: white;"|Niet van toepassing (code = '1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
|style="background-color: white;"|Eerst oplossen in water (code = '27') | |style="background-color: white;"|Eerst oplossen in water (code = '27') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
|style="background-color: white;"|Mond spoelen, daarna uitspugen (code = '69') | |style="background-color: white;"|Mond spoelen, daarna uitspugen (code = '69') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|2 maal per dag 10 à 15 ml | |style="background-color: white;"|2 maal per dag 10 à 15 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_413_6_MA_1 | |style="background-color: white;"|MBH_413_6_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_6 | |style="background-color: white;"|MBH_413_6 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_7_TA_1 | |style="background-color: white;"|MBH_413_7_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|HUMULINE NPH INJ 100IE/ML PATROON 3ML | |style="background-color: white;"|HUMULINE NPH INJ 100IE/ML PATROON 3ML (code = '870471') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen, elke dag om 08:00, 14:00 en 20:00 uur 16IE, subcutaan | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen, elke dag om 08:00, 14:00 en 20:00 uur 16IE, subcutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Subcutaan (code = '21') | |style="background-color: white;"|Subcutaan (code = '21') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|Elke dag om 08:00, 14:00 en 20:00 16 internationale eenheid | |style="background-color: white;"|Elke dag om 08:00, 14:00 en 20:00 16 internationale eenheid | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_413_7_MA_1 | |style="background-color: white;"|MBH_413_7_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_7 | |style="background-color: white;"|MBH_413_7 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_8_TA_1 | |style="background-color: white;"|MBH_413_8_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|ALDARA CREME 50MG/G IN SACHET | |style="background-color: white;"|ALDARA CREME 50MG/G IN SACHET (code = '1198521') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="6"| | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen, cutaan | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen, cutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Subcutaan (code = '21') | |style="background-color: white;"|Subcutaan (code = '21') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
|style="background-color: white;"|Voor de nacht (code = '1128') | |style="background-color: white;"|Voor de nacht (code = '1128') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
|style="background-color: white;"|Aanbrengen (code = '1018') | |style="background-color: white;"|Aanbrengen (code = '1018') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|Op maandag, woensdag en vrijdag | |style="background-color: white;"|Op maandag, woensdag en vrijdag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_413_8_MA_1 | |style="background-color: white;"|MBH_413_8_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_8 | |style="background-color: white;"|MBH_413_8 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_9_TA_1 | |style="background-color: white;"|MBH_413_9_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|INEGY TABLET 10/20MG | |style="background-color: white;"|INEGY TABLET 10/20MG (code = '1719785') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, 1 maal daags 1 stuk ’s avonds innemen, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, 1 maal daags 1 stuk ’s avonds innemen, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk 's avonds | |style="background-color: white;"|1 maal per dag 1 stuk 's avonds | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_413_9_MA_1 | |style="background-color: white;"|MBH_413_9_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_9 | |style="background-color: white;"|MBH_413_9 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_10_TA_1 | |style="background-color: white;"|MBH_413_10_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|MARVELON TABLET | |style="background-color: white;"|MARVELON TABLET (code = '416681') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|Gedurende 21 dagen 1 maal per dag 1 stuk | |style="background-color: white;"|Gedurende 21 dagen 1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Herhaalperiode cyclisch schema | ||
|style="background-color: white;"|28 dagen | |style="background-color: white;"|28 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_413_10_MA_1 | |style="background-color: white;"|MBH_413_10_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_10 | |style="background-color: white;"|MBH_413_10 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_11_TA_1 | |style="background-color: white;"|MBH_413_11_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|FUCIDIN CREME 20MG/G | |style="background-color: white;"|FUCIDIN CREME 20MG/G (code = '420956') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Cutaan (code = '7') | |style="background-color: white;"|Cutaan (code = '7') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
|style="background-color: white;"|Dun aanbrengen (code = '1033') | |style="background-color: white;"|Dun aanbrengen (code = '1033') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie 1 | |colspan="2"|Doseerinstructie 1 | ||
|style="background-color: white;"|Eerst gedurende 2 weken 1 maal per dag 3 gram | |style="background-color: white;"|Eerst gedurende 2 weken 1 maal per dag 3 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie 2 | |colspan="2"|Doseerinstructie 2 | ||
|style="background-color: white;"|Dan gedurende 3 weken 1 maal per dag 2 gram | |style="background-color: white;"|Dan gedurende 3 weken 1 maal per dag 2 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie 3 | |colspan="2"|Doseerinstructie 3 | ||
|style="background-color: white;"|Dan gedurende 6 dagen 1 maal per dag 1 gram | |style="background-color: white;"|Dan gedurende 6 dagen 1 maal per dag 1 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_413_11_MA_1 | |style="background-color: white;"|MBH_413_11_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_11 | |style="background-color: white;"|MBH_413_11 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_12_TA_1 | |style="background-color: white;"|MBH_413_12_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|3 sep 2018, om 11:25 | |style="background-color: white;"|3 sep 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|CODEINEFOSFAAT PCH TABLET 10MG | |style="background-color: white;"|CODEINEFOSFAAT PCH TABLET 10MG (code = '874965') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|Bij hoest 3 à 4 maal per uur 1 stuk | |style="background-color: white;"|Bij hoest 3 à 4 maal per uur 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_413_12_MA_1 | |style="background-color: white;"|MBH_413_12_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_12 | |style="background-color: white;"|MBH_413_12 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_13_TA_1 | |style="background-color: white;"|MBH_413_13_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|6 aug 2018, om 09:12 | |style="background-color: white;"|6 aug 2018, om 09:12 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 6 aug 2018, gedurende 8 dagen | |style="background-color: white;"|Vanaf 6 aug 2018, gedurende 8 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|MORFINEHYDROCHLORIDE 5MG/ML DELTEC CAS 100ML PA | |style="background-color: white;"|MORFINEHYDROCHLORIDE 5MG/ML DELTEC CAS 100ML PA (code = '2124823') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 6 aug 2018, gedurende 8 dagen, 0.5 ml per uur parenteraal | |style="background-color: white;"|Vanaf 6 aug 2018, gedurende 8 dagen, 0.5 ml per uur parenteraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Parenteraal (code = '10') | |style="background-color: white;"|Parenteraal (code = '10') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|0.5 ml per uur | |style="background-color: white;"|0.5 ml per uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_413_13_MA_1 | |style="background-color: white;"|MBH_413_13_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_13 | |style="background-color: white;"|MBH_413_13 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_13_TA_2 | |style="background-color: white;"|MBH_413_13_TA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|14 aug 2018, om 11:25 | |style="background-color: white;"|14 aug 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 14 aug 2018, gedurende 8 dagen | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 8 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|MORFINEHYDROCHLORIDE 5MG/ML DELTEC CAS 100ML PA | |style="background-color: white;"|MORFINEHYDROCHLORIDE 5MG/ML DELTEC CAS 100ML PA (code = '2124823') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 14 aug 2018, gedurende 8 dagen, 0.2 tot 0.5 ml per uur parenteraal | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 8 dagen, 0.2 tot 0.5 ml per uur parenteraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Parenteraal (code = '10') | |style="background-color: white;"|Parenteraal (code = '10') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|0.2 à 0.5 ml per uur | |style="background-color: white;"|0.2 à 0.5 ml per uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_413_13_MA_2 | |style="background-color: white;"|MBH_413_13_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_13 | |style="background-color: white;"|MBH_413_13 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_14_TA_1 | |style="background-color: white;"|MBH_413_14_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|3 sep 2018, om 11:25 | |style="background-color: white;"|3 sep 2018, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 16 aug 2018, tot nader order | |style="background-color: white;"|Vanaf 16 aug 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG | |style="background-color: white;"|DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG (code = '1013602') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister), transdermaal | |style="background-color: white;"|Tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister), transdermaal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Transdermaal (code = '58') | |style="background-color: white;"|Transdermaal (code = '58') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur | |style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Relatie naar medicatieafspraak | ||
|style="background-color: white;"|MBH_413_14_MA_1 | |style="background-color: white;"|MBH_413_14_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_14 | |style="background-color: white;"|MBH_413_14 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_15_TA_1 | |style="background-color: white;"|MBH_413_15_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Afspraakdatum | ||
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 4 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 4 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - Product specificatie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="16"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Product naam | |||
|style="background-color: white;"|Haparine 100 ie= 10 ml | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Omschrijving | |||
|style="background-color: white;"|Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|Farmaceutische vorm | ||
|style="background-color: white;"| | |style="background-color: white;"|Vloeistof (code = '434') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Ingredient | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|| | ||Ingredient code | ||
|style="background-color: white;"| | |style="background-color: white;"|Heparinum natricum (code = '898724') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|| | ||Sterkte | ||
|style="background-color: white;"| | |style="background-color: white;"|100 internationale eenheid per 10 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingredient | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | ||Ingredient code | ||
|style="background-color: white;"| | |style="background-color: white;"|WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|MBH identificatie | ||Sterkte | ||
|style="background-color: white;"|MBH_413_15 | |style="background-color: white;"|1 stuk per 10 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingredient | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
||Ingredient code | |||
|style="background-color: white;"|NATRII CHLORIDUM (code = '256390') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
||Sterkte | |||
|style="background-color: white;"|0.09 gram per 10 ml | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Gebruiksinstructie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="4"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Omschrijving | |||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 4 dagen, 2 maal per dag 10 ml, parenteraal | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Toedieningsweg | |||
|style="background-color: white;"|Parenteraal (code = '10') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Doseerinstructie | |||
|style="background-color: white;"|2 maal per dag 10 ml | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Relatie naar medicatieafspraak | |||
|style="background-color: white;"|MBH_413_15_MA_1 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|MBH identificatie | |||
|style="background-color: white;"|MBH_413_15 | |||
|} | |} | ||
===Verstrekkingen XXX_Strengersz === | ===Verstrekkingen XXX_Strengersz === | ||
<section begin=MVE_XXX_Strengersz /> | <section begin=MVE_XXX_Strengersz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_9_MVE_1 | |style="background-color: white;"|MBH_413_9_MVE_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Datum | ||
|style="background-color: white;"|3 sep 2018, om 10:35 | |style="background-color: white;"|3 sep 2018, om 10:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekte hoeveelheid | ||
|style="background-color: white;"|90 stuks | |style="background-color: white;"|90 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|INEGY TABLET 10/20MG | |style="background-color: white;"|INEGY TABLET 10/20MG (code = '1719785') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Distributievorm | ||
|style="background-color: white;"|Geïndividualiseerd distributiesysteem (code = '1') | |style="background-color: white;"|Geïndividualiseerd distributiesysteem (code = '1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_9 | |style="background-color: white;"|MBH_413_9 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_15_MVE_1 | |style="background-color: white;"|MBH_413_15_MVE_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Datum | ||
|style="background-color: white;"|3 sep 2018, om 10:35 | |style="background-color: white;"|3 sep 2018, om 10:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Verstrekte hoeveelheid | ||
|style="background-color: white;"|100 ml | |style="background-color: white;"|100 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - Product specificatie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="16"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Product naam | |||
|style="background-color: white;"|Haparine 100 ie= 10 ml | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Omschrijving | |||
|style="background-color: white;"|Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Farmaceutische vorm | |||
|style="background-color: white;"|Vloeistof (code = '434') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingredient | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | ||Ingredient code | ||
|style="background-color: white;"| | |style="background-color: white;"|Heparinum natricum (code = '898724') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | ||Sterkte | ||
|style="background-color: white;"|100 internationale eenheid per 10 ml | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingredient | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
||Ingredient code | |||
|style="background-color: white;"|WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
||Sterkte | |||
|style="background-color: white;"|1 stuk per 10 ml | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingredient | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
||Ingredient code | |||
|style="background-color: white;"|NATRII CHLORIDUM (code = '256390') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
||Sterkte | |||
|style="background-color: white;"|0.09 gram per 10 ml | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Relatie naar verstrekkingsverzoek | |||
|style="background-color: white;"|MBH_513_15_VV_1 | |style="background-color: white;"|MBH_513_15_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_15 | |style="background-color: white;"|MBH_413_15 | ||
|}<section end=MVE_XXX_Strengersz /> | |}<section end=MVE_XXX_Strengersz /> | ||
| Regel 5.264: | Regel 5.424: | ||
<section begin=MGB_XXX_Strengersz /> | <section begin=MGB_XXX_Strengersz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_1_MGB_1 | |style="background-color: white;"|MBH_413_1_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|3 sep 2018, om 16:25 | |style="background-color: white;"|3 sep 2018, om 16:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Volgens afspraak indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 à 2 maal per dag 1 stuk | |style="background-color: white;"|1 à 2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_413_1_MA_1 | |style="background-color: white;"|MBH_413_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_1 | |style="background-color: white;"|MBH_413_1 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_2_MGB_1 | |style="background-color: white;"|MBH_413_2_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|3 sep 2018, om 14:25 | |style="background-color: white;"|3 sep 2018, om 14:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen, exact iedere 3 uur 16 IE, subcutaan | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 14 dagen, exact iedere 3 uur 16 IE, subcutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Subcutaan (code = '21') | |style="background-color: white;"|Subcutaan (code = '21') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|Exact iedere 3 uur 16 internationale eenheid | |style="background-color: white;"|Exact iedere 3 uur 16 internationale eenheid | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_413_2_MA_1 | |style="background-color: white;"|MBH_413_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_2 | |style="background-color: white;"|MBH_413_2 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_3_MGB_1 | |style="background-color: white;"|MBH_413_3_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|3 sep 2018, om 10:45 | |style="background-color: white;"|3 sep 2018, om 10:45 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Volgens afspraak indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | |style="background-color: white;"|Vanaf 15 jul 2018, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|3 maal per dag 1 à 2 stuks | |style="background-color: white;"|3 maal per dag 1 à 2 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_413_3_MA_1 | |style="background-color: white;"|MBH_413_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_3 | |style="background-color: white;"|MBH_413_3 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_4_MGB_1 | |style="background-color: white;"|MBH_413_4_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|19 aug 2018, om 13:44 | |style="background-color: white;"|19 aug 2018, om 13:44 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 14 aug 2018, tot en met 19 aug 2018 23:59 | |style="background-color: white;"|Vanaf 14 aug 2018, tot en met 19 aug 2018 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 14 aug 2018 tot en met 19 aug 2018, 3 maal per dag aanbrengen, cutaan | |style="background-color: white;"|Vanaf 14 aug 2018 tot en met 19 aug 2018, 3 maal per dag aanbrengen, cutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Cutaan (code = '7') | |style="background-color: white;"|Cutaan (code = '7') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
|style="background-color: white;"|Aanbrengen (code = '1018') | |style="background-color: white;"|Aanbrengen (code = '1018') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|3 maal per dag | |style="background-color: white;"|3 maal per dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_413_4_MA_1 | |style="background-color: white;"|MBH_413_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_4 | |style="background-color: white;"|MBH_413_4 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_5_MGB_1 | |style="background-color: white;"|MBH_413_5_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|3 sep 2018, om 12:38 | |style="background-color: white;"|3 sep 2018, om 12:38 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Ibuprofen PCH tablet 600mg | |style="background-color: white;"|Ibuprofen PCH tablet 600mg (code = '641898') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen, 2 maal per dag ¼ tablet | |style="background-color: white;"|Vanaf 14 aug 2018, gedurende 30 dagen, 2 maal per dag ¼ tablet | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|2 maal per dag 0.25 stuk | |style="background-color: white;"|2 maal per dag 0.25 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_413_5_MA_1 | |style="background-color: white;"|MBH_413_5_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_5 | |style="background-color: white;"|MBH_413_5 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_6_MGB_1 | |style="background-color: white;"|MBH_413_6_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|3 sep 2018, om 21:37 | |style="background-color: white;"|3 sep 2018, om 21:37 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 1 dag | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 1 dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Waterstofperoxide 30MG/ML | |style="background-color: white;"|Waterstofperoxide 30MG/ML (code = '67016') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="6"| | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 1 dag, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 1 dag, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Niet van toepassing (code = '1') | |style="background-color: white;"|Niet van toepassing (code = '1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
|style="background-color: white;"|Eerst oplossen in water (code = '27') | |style="background-color: white;"|Eerst oplossen in water (code = '27') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
|style="background-color: white;"|Mond spoelen, daarna uitspugen (code = '69') | |style="background-color: white;"|Mond spoelen, daarna uitspugen (code = '69') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|2 maal per dag 10 à 15 ml | |style="background-color: white;"|2 maal per dag 10 à 15 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_413_6_MA_1 | |style="background-color: white;"|MBH_413_6_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_6 | |style="background-color: white;"|MBH_413_6 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_7_MGB_1 | |style="background-color: white;"|MBH_413_7_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|3 sep 2018, om 14:05 | |style="background-color: white;"|3 sep 2018, om 14:05 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018 14:00, tot en met 3 sep 2018 14:05 | |style="background-color: white;"|Vanaf 3 sep 2018 14:00, tot en met 3 sep 2018 14:05 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018 14:00 tot en met 3 sep 2018 14:05, om 14:00 16IE | |style="background-color: white;"|Vanaf 3 sep 2018 14:00 tot en met 3 sep 2018 14:05, om 14:00 16IE | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Subcutaan (code = '21') | |style="background-color: white;"|Subcutaan (code = '21') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|Elke dag om 16 internationale eenheid | |style="background-color: white;"|Elke dag om 16 internationale eenheid | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_413_7_MA_1 | |style="background-color: white;"|MBH_413_7_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_7 | |style="background-color: white;"|MBH_413_7 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_7_MGB_2 | |style="background-color: white;"|MBH_413_7_MGB_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|3 sep 2018, om 20:10 | |style="background-color: white;"|3 sep 2018, om 20:10 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018 20:00, tot en met 3 sep 2018 20:05 | |style="background-color: white;"|Vanaf 3 sep 2018 20:00, tot en met 3 sep 2018 20:05 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018 20:00 tot en met 3 sep 2018 20:05, om 20:00 16IE | |style="background-color: white;"|Vanaf 3 sep 2018 20:00 tot en met 3 sep 2018 20:05, om 20:00 16IE | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Subcutaan (code = '21') | |style="background-color: white;"|Subcutaan (code = '21') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|Elke dag om 16 internationale eenheid | |style="background-color: white;"|Elke dag om 16 internationale eenheid | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_413_7_MA_1 | |style="background-color: white;"|MBH_413_7_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_7 | |style="background-color: white;"|MBH_413_7 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_8_MGB_1 | |style="background-color: white;"|MBH_413_8_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|3 sep 2018, om 23:59 | |style="background-color: white;"|3 sep 2018, om 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Volgens afspraak indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|IMIQUIMOD 50MG/G CREME | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
|style="background-color: white;"|Voor de nacht (code = '1128') | |style="background-color: white;"|Voor de nacht (code = '1128') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
|style="background-color: white;"|Aanbrengen (code = '1018') | |style="background-color: white;"|Aanbrengen (code = '1018') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|Op maandag, woensdag en vrijdag | |style="background-color: white;"|Op maandag, woensdag en vrijdag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_413_8_MA_1 | |style="background-color: white;"|MBH_413_8_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_8 | |style="background-color: white;"|MBH_413_8 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_9_MGB_1 | |style="background-color: white;"|MBH_413_9_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|3 sep 2018, om 22:35 | |style="background-color: white;"|3 sep 2018, om 22:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Volgens afspraak indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, 1 maal daags ’s avonds innemen | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, 1 maal daags ’s avonds innemen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk 's avonds | |style="background-color: white;"|1 maal per dag 1 stuk 's avonds | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_413_9_MA_1 | |style="background-color: white;"|MBH_413_9_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_9 | |style="background-color: white;"|MBH_413_9 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_10_MGB_1 | |style="background-color: white;"|MBH_413_10_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|3 sep 2018, om 09:35 | |style="background-color: white;"|3 sep 2018, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Volgens afspraak indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Ethinyl estradiol/desogestrel tablet 30/150ug (Marvelon) | |style="background-color: white;"|Ethinyl estradiol/desogestrel tablet 30/150ug (Marvelon) (code = '16292') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|Gedurende 21 dagen 1 maal per dag 1 stuk | |style="background-color: white;"|Gedurende 21 dagen 1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Herhaalperiode cyclisch schema | ||
|style="background-color: white;"|28 dagen | |style="background-color: white;"|28 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_413_10_MA_1 | |style="background-color: white;"|MBH_413_10_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_10 | |style="background-color: white;"|MBH_413_10 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_11_MGB_1 | |style="background-color: white;"|MBH_413_11_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|3 sep 2018, om 15:35 | |style="background-color: white;"|3 sep 2018, om 15:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Volgens afspraak indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Fusidinezuur creme 20mg/g | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="6"| | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
|style="background-color: white;"|Dun aanbrengen (code = '1033') | |style="background-color: white;"|Dun aanbrengen (code = '1033') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie 1 | |colspan="2"|Doseerinstructie 1 | ||
|style="background-color: white;"|Eerst gedurende 2 weken 1 maal per dag 3 gram | |style="background-color: white;"|Eerst gedurende 2 weken 1 maal per dag 3 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|Dan gedurende 3 weken 1 maal per dag 2 gram | |style="background-color: white;"|Dan gedurende 3 weken 1 maal per dag 2 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|Dan gedurende 6 dagen 1 maal per dag 1 gram | |style="background-color: white;"|Dan gedurende 6 dagen 1 maal per dag 1 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_413_11_MA_1 | |style="background-color: white;"|MBH_413_11_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_11 | |style="background-color: white;"|MBH_413_11 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_12_MGB_1 | |style="background-color: white;"|MBH_413_12_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|3 sep 2018, om 22:35 | |style="background-color: white;"|3 sep 2018, om 22:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Volgens afspraak indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9') | |style="background-color: white;"|Oraal (code = '9') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|Bij hoest 3 à 4 maal per uur 1 stuk | |style="background-color: white;"|Bij hoest 3 à 4 maal per uur 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_413_12_MA_1 | |style="background-color: white;"|MBH_413_12_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_12 | |style="background-color: white;"|MBH_413_12 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_14_MGB_1 | |style="background-color: white;"|MBH_413_14_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|3 sep 2018, om 22:35 | |style="background-color: white;"|3 sep 2018, om 22:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Volgens afspraak indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Tot nader order | |style="background-color: white;"|Tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister). | |style="background-color: white;"|Vanaf 3 sep 2018, tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister). | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Transdermaal (code = '58') | |style="background-color: white;"|Transdermaal (code = '58') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur | |style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_413_14_MA_1 | |style="background-color: white;"|MBH_413_14_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_14 | |style="background-color: white;"|MBH_413_14 | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_413_15_MGB_1 | |style="background-color: white;"|MBH_413_15_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Registratiedatum | ||
|style="background-color: white;"|3 sep 2018, om 10:35 | |style="background-color: white;"|3 sep 2018, om 10:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gebruik indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Volgens afspraak indicator | ||
|style="background-color: white;"|True | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|gebruiksperiode | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 4 dagen | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 4 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Voorschrijver | ||
|style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geneesmiddel - Product specificatie | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="16"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Product naam | |||
|style="background-color: white;"|Haparine 100 ie= 10 ml | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Omschrijving | |||
|style="background-color: white;"|Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Farmaceutische vorm | |||
|style="background-color: white;"|Vloeistof (code = '434') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingredient | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
||Ingredient code | |||
|style="background-color: white;"|Heparinum natricum (code = '898724') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
||Sterkte | |||
|style="background-color: white;"|100 internationale eenheid per 10 ml | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingredient | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
||Ingredient code | |||
|style="background-color: white;"|WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
||Sterkte | |||
|style="background-color: white;"|1 stuk per 10 ml | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Ingredient | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="3"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
||Ingredient code | |||
|style="background-color: white;"|NATRII CHLORIDUM (code = '256390') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | ||Sterkte | ||
|style="background-color: white;"| | |style="background-color: white;"|0.09 gram per 10 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Omschrijving | |colspan="2"|Omschrijving | ||
|style="background-color: white;"|Vanaf 3 sep 2018, gedurende 4 dagen, 2 maal per dag 10 ml | |style="background-color: white;"|Vanaf 3 sep 2018, gedurende 4 dagen, 2 maal per dag 10 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Parenteraal (code = '10') | |style="background-color: white;"|Parenteraal (code = '10') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
||Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|2 maal per dag 10 ml | |style="background-color: white;"|2 maal per dag 10 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Gerelateerde afspraak: MA | ||
|style="background-color: white;"|MBH_413_15_MA_1 | |style="background-color: white;"|MBH_413_15_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Auteur | ||
|style="background-color: white;"|Patiënt | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_413_15 | |style="background-color: white;"|MBH_413_15 | ||
|}<section end=MGB_XXX_Strengersz /> | |}<section end=MGB_XXX_Strengersz /> | ||
Versie van 1 okt 2018 13:51
|
Deze pagina is nog in bewerking |

Addenda voor inhoudelijke gegevens
Patiënt J. XXX_Amaya
| Patient | |||
| Gegevenselement | Waarde | ||
| Naamgegevens | J. XXX_Amaya | ||
| Patient identificatienummer | 999911764 [BSN] | ||
| Patient identificatienummer | 51107 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
| Geboortedatum | 6 aug 1964 | ||
| Geslacht | Man (code = 'M') | ||
Medicatieafspraken XXX_Amaya
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_513_1_MA_1 | ||
| Afspraakdatum | 2 sep 2018, om 11:25 | ||
| gebruiksperiode | Vanaf 2 sep 2018, gedurende 60 dagen | ||
| Geannuleerd indicator | True | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
| Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 2 sep 2018, gedurende 60 dagen, 10 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 10 maal per dag 1 stuk | ||
| MBH identificatie | MBH_513_1 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_513_1_MA_2 | ||
| Afspraakdatum | 3 sep 2018, om 09:00 | ||
| gebruiksperiode | Vanaf 3 sep 2018, gedurende 60 dagen | ||
| Voorschrijver | Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
| Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_513_1 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_513_2_MA_2 | ||
| Afspraakdatum | 3 sep 2018, om 14:32 | ||
| gebruiksperiode | Vanaf 3 sep 2018, tot nader order | ||
| Relatie naar afspraak of gebruik: TA | MBH_513_2_TA_1 | ||
| Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
| Reden afspraak | Opname (code = '305335007') | ||
| Geneesmiddel | Furosemide tablet 40mg (code = '5967') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, tot nader order, 1 maal daags 1 stuk, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| Toelichting | Toedieningsafspraak van apotheker ontvangen, geen medicatieafspraak van voorschrijver ontvangen. Deze nieuwe medicatieafspraak is gebaseerd op de toedieningsafspraak: MBH_513_2_TA_1 | ||
| MBH identificatie | MBH_513_2 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_513_3_MA_1 | ||
| Afspraakdatum | 3 sep 2018, om 14:32 | ||
| gebruiksperiode | Vanaf 3 sep 2018, gedurende 28 dagen | ||
| Relatie naar afspraak of gebruik: MGB | MBH_513_3_MGB_1 | ||
| Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
| Reden afspraak | Opname (code = '305335007') | ||
| Reden van voorschrijven | Andere maligniteit bloed/lymfestelsel (code = 'B74') | ||
| Geneesmiddel | Methotrexaat tablet 2,5mg (code = '6009') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, gedurende 28 dagen, 1 maal per week 5 stuks, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per week 5 stuks | ||
| MBH identificatie | MBH_513_3 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_513_4_MA_1 | ||
| Afspraakdatum | 29 aug 2018, om 09:35 | ||
| gebruiksperiode | Vanaf 29 aug 2018, gedurende 10 dagen | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
| Geneesmiddel | FENETICILLINE CAPSULE 500MG (code = '17205') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 29 aug 2018, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 3 maal per dag 1 stuk | ||
| Lichaamslengte | 155 cm | ||
| Lichaamsgewicht | 54 kg | ||
| Aanvullende informatie | Bewust hoge dosering (code = '1') | ||
| Toelichting | In overleg met specialist | ||
| MBH identificatie | MBH_513_4 | ||
Verstrekkingsverzoeken XXX_Amaya
| Verstrekkingsverzoek | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_513_2_VV_2 | ||
| Datum | 16 aug 2018, om 14:32 | ||
| Auteur | Hans van Doorn - Huisartsen, niet nader gespecificeerd. Ziekenhuis Stitswerd | ||
| Te verstrekken hoeveelheid | 30 stuks | ||
| Geneesmiddel | Furosemide tablet 40mg (code = '5967') | ||
| Beoogd verstrekker | Apotheek De Gulle Gaper | ||
| Toelichting | Nog in te vullen, zie word... | ||
| Relatie naar medicatieafspraak | MBH_513_2_MA_2 | ||
| MBH identificatie | MBH_513_2 | ||
| Verstrekkingsverzoek | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_513_4_VV_1 | ||
| Datum | 11 aug 2018, om 09:35 | ||
| Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Te verstrekken hoeveelheid | 40 stuks | ||
| Geneesmiddel | FENETICILLINE CAPSULE 500MG (code = '17205') | ||
| Beoogd verstrekker | Apotheek De Gulle Gaper | ||
| Afleverlocatie | Huisadres patiënt | ||
| Aanvullende wensen | Bezorgen (code = '3') | ||
| Relatie naar medicatieafspraak | MBH_513_4_MA_1 | ||
| MBH identificatie | MBH_513_4 | ||
Toedieningsafspraken XXX_Amaya
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_513_1_TA_1 | ||
| Afspraakdatum | 3 sep 2018, om 12:25 | ||
| gebruiksperiode | Vanaf 3 sep 2018, gedurende 60 dagen | ||
| Geannuleerd indicator | True | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| Relatie naar medicatieafspraak | MBH_513_1_MA_2 | ||
| MBH identificatie | MBH_513_1 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_513_2_TA_1 | ||
| Afspraakdatum | 27 aug 2018, om 14:52 | ||
| gebruiksperiode | Vanaf 27 aug 2018, tot nader order | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Reden afspraak | Opname | ||
| Geneesmiddel | FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 27 aug 2018, tot nader order, 1 maal daags 1 stuk, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| Relatie naar medicatieafspraak | MBH_513_2_MA_1 | ||
| MBH identificatie | MBH_513_2 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_513_4_TA_1 | ||
| Afspraakdatum | 29 aug 2018, om 09:45 | ||
| gebruiksperiode | Vanaf 29 aug 2018, gedurende 10 dagen | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | AMOXICILLINE PCH CAPSULE 500MG (code = '646083') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 29 aug 2018, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 3 maal per dag 1 stuk | ||
| Aanvullende informatie | Gebruiksinstructie gegeven (code = '10') | ||
| Toelichting | Wegens niet leverbaar zijn van Broxil | ||
| Relatie naar medicatieafspraak | MBH_513_4_MA_1 | ||
| MBH identificatie | MBH_513_4 | ||
Verstrekkingen XXX_Amaya
| Verstrekking | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_513_2_MVE_1 | ||
| Aanschrijfdatum | 3 sep 2018, om 14:32 | ||
| Verstrekker | Apotheek de Gulle Gaper | ||
| Verstrekte hoeveelheid | 30 stuks | ||
| Geneesmiddel | FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148') | ||
| Relatie naar verstrekkingsverzoek | MBH_513_2_VV_2 | ||
| MBH identificatie | MBH_513_2 | ||
| Verstrekking | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_513_4_MVE_1 | ||
| Datum | 29 aug 2018, om 09:45 | ||
| Verstrekker | Apotheek de Gulle Gaper | ||
| Verstrekte hoeveelheid | 30 stuks | ||
| Geneesmiddel | AMOXICILLINE PCH CAPSULE 500MG (code = '646083') | ||
| Afleverlocatie | Huisadres patiënt | ||
| Aanvullende informatie | Aantal bewust gewijzigd (code = '1') | ||
| Toelichting | Patiënt gaf aan nog wat op voorraad te hebben, wens patiënt om minder te verstrekken. | ||
| Relatie naar verstrekkingsverzoek | MBH_513_4_VV_1 | ||
| MBH identificatie | MBH_513_4 | ||
Medicatiegebruik XXX_Amaya
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_513_2_MGB_1 | ||
| Registratiedatum | 1 sep 2018, om 15:39 | ||
| Gebruik indicator | True | ||
| gebruiksperiode | Vanaf 1 sep 2018, tot nader order | ||
| Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
| Geneesmiddel | Furosemide tablet 40mg (code = '5967') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 1 sep 2018, tot nader order, 1 maal daags 1 stuk, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| Gerelateerde afspraak: MA | MBH_513_2_MA_1 | ||
| Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
| MBH identificatie | MBH_513_2 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_513_2_MGB_2 | ||
| Registratiedatum | 3 sep 2018, om 20:40 | ||
| Gebruik indicator | True | ||
| gebruiksperiode | Vanaf 2 sep 2018, tot nader order | ||
| Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
| Geneesmiddel | Furosemide tablet 40mg (code = '5967') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 2 sep 2018, tot nader order, 1 maal daags 1 stuk, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| Gerelateerde afspraak: MA | MBH_513_2_MA_1 | ||
| Informant | Persoon: M. XXX_Amaya - Mantelzorger. | ||
| Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
| MBH identificatie | MBH_513_2 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_513_2_MGB_3 | ||
| Registratiedatum | 3 sep 2018, om 21:39 | ||
| Gebruik indicator | True | ||
| gebruiksperiode | Vanaf 3 sep 2018, tot nader order | ||
| Geneesmiddel | Furosemide tablet 40mg (code = '5967') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, tot nader order, 1 maal daags 1 stuk, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| Gerelateerde afspraak: MA | MBH_513_2_MA_1 | ||
| Informant | Zorgverlener: Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
| MBH identificatie | MBH_513_2 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_5132_2_MGB_2 | ||
| Registratiedatum | 16 aug 2018, om 20:59 | ||
| Gebruik indicator | True | ||
| gebruiksperiode | Vanaf 16 aug 2018, gedurende 1 dag | ||
| Geneesmiddel | TEMAZEPAM APOTEX TABLET 10MG (code = '13806769') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf T, gedurende 1 dag, 1 maal daags 1 stuk, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| Gerelateerde verstrekking | MBH_5132_2_MVE_1 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_5132_2 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_513_3_MGB_1 | ||
| Registratiedatum | 31 aug 2018, om 20:59 | ||
| Gebruik indicator | True | ||
| gebruiksperiode | Vanaf 26 aug 2018, tot en met 31 aug 2018 23:59 | ||
| Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
| Geneesmiddel | Methotrexaat tablet 2,5mg (code = '6009') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 26 aug 2018 tot en met 31 aug 2018, 1 maal per week 5 stuks, oraal | ||
| Doseerinstructie | 1 maal per week 5 stuks | ||
| Gerelateerde afspraak: MA | MBH_513_3_MA_1 | ||
| Auteur | Patiënt | ||
| Reden gebruik | Lymfekanker | ||
| MBH identificatie | MBH_513_3 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_513_4_MGB_1 | ||
| Registratiedatum | 30 aug 2018, om 22:35 | ||
| Gebruik indicator | True | ||
| Volgens afspraak indicator | False | ||
| gebruiksperiode | Vanaf 29 aug 2018, tot en met 30 aug 2018 23:59 | ||
| Geneesmiddel | AMOXICILLINE CAPSULE 250MG (code = '20044') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 29 aug 2018 tot en met 30 aug 2018, 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| Gerelateerde afspraak: MA | MBH_513_4_MA_1 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_513_4 | ||
Patiënt Pauline P. XXX_Bourgonje
| Patient | |||
| Gegevenselement | Waarde | ||
| Naamgegevens | Pauline P. XXX_Bourgonje | ||
| Patient identificatienummer | 999911296 [BSN] | ||
| Patient identificatienummer | 12102 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
| Geboortedatum | 1 aug 1964 | ||
| Geslacht | Vrouw (code = 'F') | ||
Medicatieafspraken XXX_Bourgonje
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_123_1_MA_1 | ||
| Afspraakdatum | 27 aug 2018, om | ||
| gebruiksperiode | Vanaf 27 aug 2018, tot nader order | ||
| Voorschrijver | Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost | ||
| Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
| Geneesmiddel | Cetomacrogolcreme met vaseline 10% (code = '133329') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 27 aug 2018, Zo nodig 2 maal daags aanbrengen, op de huid | ||
| Toedieningsweg | Cutaan (code = '53') | ||
| Aanvullende instructie | Aanbrengen (code = '1018') | ||
| Doseerinstructie | Zo nodig 2 maal per dag | ||
| MBH identificatie | MBH_123_1 | ||
Verstrekkingsverzoeken XXX_Bourgonje
| Verstrekkingsverzoek | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_123_1_VV_1 | ||
| Datum | 27 aug 2018, om | ||
| Auteur | Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost | ||
| Te verstrekken hoeveelheid | 100 gram | ||
| Geneesmiddel | Cetomacrogolcreme met vaseline 10% (code = '133329') | ||
| Beoogd verstrekker | Apotheek De Gulle Gaper | ||
| Relatie naar medicatieafspraak | MBH_123_1_MA_1 | ||
| MBH identificatie | MBH_123_1 | ||
Toedieningsafspraken XXX_Bourgonje
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_123_1_TA_1 | ||
| Afspraakdatum | 27 aug 2018, om 00:00 | ||
| gebruiksperiode | Vanaf 27 aug 2018, tot nader order | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 27 aug 2018, Zo nodig 2 maal daags aanbrengen, op de huid | ||
| Toedieningsweg | Cutaan (code = '53') | ||
| Aanvullende instructie | Aanbrengen (code = '1018') | ||
| Doseerinstructie | Zo nodig 2 maal per dag | ||
| Relatie naar medicatieafspraak | MBH_123_1_MA_1 | ||
| MBH identificatie | MBH_123_1 | ||
Verstrekkingen XXX_Bourgonje
| Verstrekking | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_123_1_MVE_1 | ||
| Datum | 27 aug 2018, om | ||
| Verstrekker | Apotheek de Gulle Gaper | ||
| Verstrekte hoeveelheid | 100 gram | ||
| Geneesmiddel | CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943') | ||
| Relatie naar verstrekkingsverzoek | MBH_123_1_VV_1 | ||
| MBH identificatie | MBH_123_1 | ||
Medicatiegebruik XXX_Bourgonje
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_123_1_MGB_1 | ||
| Registratiedatum | 12 aug 2018, om 20:58 | ||
| Gebruik indicator | True | ||
| gebruiksperiode | Vanaf 11 aug 2018, gedurende 2 dagen | ||
| Voorschrijver | Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost | ||
| Geneesmiddel | Cetomacrogolcreme met vaseline 10% (code = '133329') | ||
| Gebruiksinstructie | |||
| Aanvullende instructie | Aanbrengen (code = '1018') | ||
| Doseerinstructie | 2 maal per dag | ||
| Gerelateerde afspraak: MA | MBH_123_1_MA_1 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_123_1 | ||
Patiënt J. XXX_Cnossen
| Patient | |||
| Gegevenselement | Waarde | ||
| Naamgegevens | J. XXX_Cnossen | ||
| Patient identificatienummer | 999911740 [BSN] | ||
| Patient identificatienummer | 31105 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
| Geboortedatum | 4 aug 1964 | ||
| Geslacht | Man (code = 'M') | ||
Medicatieafspraken XXX_Cnossen
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_313_1_MA_1 | ||
| Afspraakdatum | 26 mei 2018, om 12:11 | ||
| gebruiksperiode | Vanaf 26 mei 2018, tot nader order | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
| Geneesmiddel | Tiotropium inhalatiecapsule 18ug (code = '59919') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | ||
| Toedieningsweg | Inhalatie (code = '62') | ||
| Doseerinstructie | 1 maal per dag 1 dosis | ||
| MBH identificatie | MBH_313_1 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_313_1_MA_2 | ||
| Afspraakdatum | 5 jul 2018, om 13:54 | ||
| gebruiksperiode | Vanaf 26 mei 2018, tot en met 6 jul 2018 23:59 | ||
| Stoptype | Staking | ||
| Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Indicatie vervallen (code = '9') | ||
| Geneesmiddel | Tiotropium inhalatiecapsule 18ug (code = '59919') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 26 mei 2018 tot en met 6 jul 2018, 1 maal per dag 1 dosis, inhalatie | ||
| Toedieningsweg | Inhalatie (code = '62') | ||
| Doseerinstructie | 1 maal per dag 1 dosis | ||
| MBH identificatie | MBH_313_1 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_313_2_MA_1 | ||
| Afspraakdatum | 21 apr 2017, om 10:19 | ||
| gebruiksperiode | Vanaf 21 apr 2017, tot nader order | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
| Geneesmiddel | Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 21 apr 2017, tot nader order, 1x per dag 1 druppel, in beide ogen | ||
| Toedieningsweg | Oculair (code = '7') | ||
| Aanvullende instructie | In beide ogen (code = '1026') | ||
| Doseerinstructie | 1 maal per dag 1 druppel | ||
| MBH identificatie | MBH_313_2 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_313_2_MA_2 | ||
| Afspraakdatum | 2 sep 2017, om 17:54 | ||
| gebruiksperiode | Vanaf 21 apr 2017, tot en met 2 sep 2017 17:00 | ||
| Stoptype | Staking | ||
| Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Indicatie vervallen (code = '9') | ||
| Geneesmiddel | Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 21 apr 2017 tot en met 2 sep 2017 17:00, 1x per dag 1 druppel, in beide ogen | ||
| Toedieningsweg | Oculair (code = '7') | ||
| Aanvullende instructie | In beide ogen (code = '1026') | ||
| Doseerinstructie | 1 maal per dag 1 druppel | ||
| MBH identificatie | MBH_313_2 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_313_3_MA_1 | ||
| Afspraakdatum | 26 mei 2018, om 12:11 | ||
| gebruiksperiode | Vanaf 26 mei 2018, tot nader order | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
| Geneesmiddel | CARBASALAATCALCIUM 100MG PO (code = '13072') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_313_3 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_313_3_MA_2 | ||
| Afspraakdatum | 30 aug 2018, om 13:54 | ||
| gebruiksperiode | Vanaf 26 mei 2018, tot en met 29 aug 2018 23:59 | ||
| Stoptype | Onderbreking | ||
| Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | CARBASALAATCALCIUM 100MG PO (code = '13072') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 26 mei 2018 tot en met 29 aug 2018, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_313_3 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_313_4_MA_1 | ||
| Afspraakdatum | 7 nov 2017, om 14:23 | ||
| gebruiksperiode | Vanaf 7 nov 2017, tot nader order | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
| Geneesmiddel | Omeprazol tablet MSR 40mg (code = '88803') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 7 nov 2017, tot nader order, 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_313_4 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_313_4_MA_2 | ||
| Afspraakdatum | 24 jan 2018, om 08:54 | ||
| gebruiksperiode | Vanaf 7 nov 2017, tot en met 23 jan 2018 23:59 | ||
| Stoptype | Onderbreking | ||
| Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | Omeprazol tablet MSR 40mg (code = '88803') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 7 nov 2017 tot en met 23 jan 2018, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_313_4 | ||
Toedieningsafspraken XXX_Cnossen
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_313_1_TA_1 | ||
| Afspraakdatum | 26 mei 2018, om 12:11 | ||
| gebruiksperiode | Vanaf 26 mei 2018, tot nader order | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | SPIRIVA INHALPDR 18MCG (code = '1476866') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | ||
| Toedieningsweg | Inhalatie (code = '62') | ||
| Doseerinstructie | 1 maal per dag 1 dosis | ||
| Relatie naar medicatieafspraak | MBH_313_1_MA_1 | ||
| MBH identificatie | MBH_313_1 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_313_1_TA_2 | ||
| Afspraakdatum | 5 jul 2018, om 13:54 | ||
| gebruiksperiode | Vanaf 26 mei 2018, tot en met 6 jul 2018 23:59 | ||
| Stoptype | Staking | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | SPIRIVA INHALPDR 18MCG (code = '1476866') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 26 mei 2018 tot en met 6 jul 2018, 1 maal per dag 1 dosis, inhalatie | ||
| Toedieningsweg | Inhalatie (code = '62') | ||
| Doseerinstructie | 1 maal per dag 1 dosis | ||
| Relatie naar medicatieafspraak | MBH_313_1_MA_2 | ||
| MBH identificatie | MBH_313_1 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_313_2_TA_1 | ||
| Afspraakdatum | 21 apr 2017, om 10:19 | ||
| gebruiksperiode | Vanaf 21 apr 2017, tot nader order | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | LATANOPROST/TIMOLOL SDZ OOGDR 0,05/5MG/ML FL 2,5ML (code = '2226294') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 21 apr 2017, tot nader order, 1x per dag 1 druppel, in beide ogen | ||
| Toedieningsweg | Oculair (code = '7') | ||
| Aanvullende instructie | In beide ogen (code = '1026') | ||
| Doseerinstructie | 1 maal per dag 1 druppel | ||
| Relatie naar medicatieafspraak | MBH_313_2_MA_1 | ||
| MBH identificatie | MBH_313_2 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_313_2_TA_2 | ||
| Afspraakdatum | 2 sep 2017, om 17:54 | ||
| gebruiksperiode | Vanaf 21 apr 2017, tot en met 2 sep 2017 17:00 | ||
| Stoptype | Staking | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | LATANOPROST/TIMOLOL SDZ OOGDR 0,05/5MG/ML FL 2,5ML (code = '2226294') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 21 apr 2017 tot en met 2 sep 2017 17:00, 1x per dag 1 druppel, in beide ogen | ||
| Toedieningsweg | Oculair (code = '7') | ||
| Aanvullende instructie | In beide ogen (code = '1026') | ||
| Doseerinstructie | 1 maal per dag 1 druppel | ||
| Relatie naar medicatieafspraak | MBH_313_2_MA_2 | ||
| MBH identificatie | MBH_313_2 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_313_3_TA_1 | ||
| Afspraakdatum | 26 mei 2018, om 12:30 | ||
| gebruiksperiode | Vanaf 26 mei 2018, tot nader order | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | CARBASALAATCALCIUM CF SACHET 100MG (code = '1113534') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| Relatie naar medicatieafspraak | MBH_313_3_MA_1 | ||
| MBH identificatie | MBH_313_3 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_313_3_TA_2 | ||
| Afspraakdatum | 30 aug 2018, om 14:54 | ||
| gebruiksperiode | Vanaf 26 mei 2018, tot en met 29 aug 2018 23:59 | ||
| Stoptype | Onderbreking | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | CARBASALAATCALCIUM CF SACHET 100MG (code = '1113534') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 26 mei 2018 tot en met 29 aug 2018, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| Relatie naar medicatieafspraak | MBH_313_3_MA_2 | ||
| MBH identificatie | MBH_313_3 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_313_4_TA_1 | ||
| Afspraakdatum | 7 nov 2017, om 15:23 | ||
| gebruiksperiode | Vanaf 7 nov 2017, tot nader order | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | OMEPRAZOL SANDOZ MUT TABLET MSR 40MG (code = '2124971') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 7 nov 2017, tot nader order, 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| Relatie naar medicatieafspraak | MBH_313_4_MA_1 | ||
| MBH identificatie | MBH_313_4 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_313_4_TA_2 | ||
| Afspraakdatum | 24 jan 2018, om 09:54 | ||
| gebruiksperiode | Vanaf 7 nov 2017, tot en met 23 jan 2018 23:59 | ||
| Stoptype | Onderbreking | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | OMEPRAZOL SANDOZ MUT TABLET MSR 40MG (code = '2124971') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 7 nov 2017 tot en met 23 jan 2018, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| Relatie naar medicatieafspraak | MBH_313_4_MA_2 | ||
| MBH identificatie | MBH_313_4 | ||
Medicatiegebruik XXX_Cnossen
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_313_1_MGB_1 | ||
| Registratiedatum | 6 jul 2018, om 12:11 | ||
| Gebruik indicator | True | ||
| gebruiksperiode | Vanaf 6 jul 2018, tot nader order | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | Tiotropium inhalatiecapsule 18ug (code = '59919') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf T-100, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | ||
| Toedieningsweg | Inhalatie (code = '62') | ||
| Doseerinstructie | 1 maal per dag 1 dosis | ||
| Gerelateerde afspraak: MA | MBH_313_1_MA_1 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_313_1 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_313_1_MGB_2 | ||
| Registratiedatum | 18 jun 2018, om 15:25 | ||
| Gebruik indicator | False | ||
| gebruiksperiode | Vanaf 8 mei 2018, tot en met 18 jun 2018 23:59 | ||
| Stoptype | Staking | ||
| Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | Tiotropium inhalatiecapsule 18ug (code = '59919') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf T-100, tot en met T-59, 1 maal per dag 1 dosis, inhalatie | ||
| Toedieningsweg | Inhalatie (code = '62') | ||
| Doseerinstructie | 1 maal per dag 1 dosis | ||
| Gerelateerde afspraak: MA | MBH_313_1_MA_2 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_313_1 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_313_2_MGB_1 | ||
| Registratiedatum | 3 apr 2017, om 10:19 | ||
| Gebruik indicator | True | ||
| gebruiksperiode | Vanaf 3 apr 2017, tot nader order | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf T-500, tot nader order, 1x per dag 1 druppel, in beide ogen | ||
| Toedieningsweg | Oculair (code = '7') | ||
| Aanvullende instructie | In beide ogen (code = '1026') | ||
| Doseerinstructie | 1 maal per dag 1 druppel | ||
| Gerelateerde afspraak: MA | MBH_313_2_MA_1 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_313_2 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_313_2_MGB_2 | ||
| Registratiedatum | 15 aug 2017, om 17:54 | ||
| Gebruik indicator | True | ||
| gebruiksperiode | Vanaf 3 apr 2017, tot en met 15 aug 2017 17:00 | ||
| Stoptype | Staking | ||
| Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf T-500, tot en met T-366 17:00, 1x per dag 1 druppel, in beide ogen | ||
| Toedieningsweg | Oculair (code = '7') | ||
| Aanvullende instructie | In beide ogen (code = '1026') | ||
| Doseerinstructie | 1 maal per dag 1 druppel | ||
| Gerelateerde afspraak: MA | MBH_313_2_MA_2 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_313_2 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_313_3_MGB_1 | ||
| Registratiedatum | 8 mei 2018, om 12:11 | ||
| Gebruik indicator | True | ||
| gebruiksperiode | Vanaf 8 mei 2018, tot nader order | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | CARBASALAATCALCIUM 100MG PO (code = '13072') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf T-100, tot nader order, 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| Gerelateerde afspraak: MA | MBH_313_3_MA_1 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_313_3 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_313_3_MGB_2 | ||
| Registratiedatum | 12 aug 2017, om 13:54 | ||
| Gebruik indicator | True | ||
| gebruiksperiode | Vanaf 8 mei 2018, tot en met 11 aug 2018 23:59 | ||
| Stoptype | Onderbreking | ||
| Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | CARBASALAATCALCIUM 100MG PO (code = '13072') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf T-100, tot en met T-5, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken vanaf T-4 | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| Gerelateerde afspraak: MA | MBH_313_3_MA_2 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_313_3 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_313_4_MGB_1 | ||
| Registratiedatum | 20 okt 2017, om 14:23 | ||
| Gebruik indicator | True | ||
| gebruiksperiode | Vanaf 20 okt 2017, tot nader order | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | Omeprazol tablet MSR 40mg (code = '88803') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf T-300, tot nader order, 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| Gerelateerde afspraak: MA | MBH_313_4_MA_1 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_313_4 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_313_4_MGB_2 | ||
| Registratiedatum | 6 jan 2018, om 08:54 | ||
| Gebruik indicator | True | ||
| gebruiksperiode | Vanaf 20 okt 2017, tot en met 5 jan 2018 23:59 | ||
| Stoptype | Onderbreking | ||
| Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | Omeprazol tablet MSR 40mg (code = '88803') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf T-300, tot en met T-223, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken vanaf T-222 | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| Gerelateerde afspraak: MA | MBH_313_4_MA_2 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_313_4 | ||
Patiënt R. XXX_Dirksz
| Patient | |||
| Gegevenselement | Waarde | ||
| Naamgegevens | R. XXX_Dirksz | ||
| Patient identificatienummer | 999911326 [BSN] | ||
| Patient identificatienummer | 11101 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
| Geboortedatum | 1 aug 1964 | ||
| Geslacht | Man (code = 'M') | ||
Medicatieafspraken XXX_Dirksz
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_113_1_MA_1 | ||
| Afspraakdatum | 15 jul 2018, om 11:25 | ||
| gebruiksperiode | Vanaf 15 jul 2018, gedurende 30 dagen | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
| Geneesmiddel | Metoclopramide zetpil 20mg (code = '6939') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 15 jul 2018, gedurende 30 dagen, zo nodig 1 maal per dag 1 stuk, rectaal | ||
| Toedieningsweg | Rectaal (code = '12') | ||
| Doseerinstructie | Zo nodig 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_113_1 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_113_2_MA_1 | ||
| Afspraakdatum | 4 aug 2018, om 14:55 | ||
| gebruiksperiode | Vanaf 4 aug 2018, gedurende 3 weken | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
| Geneesmiddel | Zestril tabel 10mg (code = '615560') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 4 aug 2018, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_113_2 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_113_3_MA_1 | ||
| Afspraakdatum | 4 aug 2018, om 14:57 | ||
| gebruiksperiode | Vanaf 4 aug 2018, tot nader order | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
| Geneesmiddel | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 4 aug 2018, tot nader order, 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_113_3 | ||
Verstrekkingsverzoeken XXX_Dirksz
| Verstrekkingsverzoek | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_113_1_VV_1 | ||
| Datum | 15 jul 2018, om 11:25 | ||
| Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Te verstrekken hoeveelheid | 30 stuks | ||
| Geneesmiddel | Metoclopramide zetpil 20mg (code = '6939') | ||
| Beoogd verstrekker | Apotheek De Gulle Gaper | ||
| Relatie naar medicatieafspraak | MBH_113_1_MA_1 | ||
| MBH identificatie | MBH_113_1 | ||
| Verstrekkingsverzoek | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_113_2_VV_1 | ||
| Datum | 4 aug 2018, om 14:55 | ||
| Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Te verstrekken hoeveelheid | 21 stuks | ||
| Geneesmiddel | Zestril tabel 10mg (code = '615560') | ||
| Beoogd verstrekker | Apotheek De Gulle Gaper | ||
| Relatie naar medicatieafspraak | MBH_113_2_MA_1 | ||
| MBH identificatie | MBH_113_2 | ||
| Verstrekkingsverzoek | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_113_3_VV_1 | ||
| Datum | 4 aug 2018, om 14:57 | ||
| Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Te verstrekken hoeveelheid | 21 stuks | ||
| Geneesmiddel | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891') | ||
| Beoogd verstrekker | Apotheek De Gulle Gaper | ||
| Relatie naar medicatieafspraak | MBH_113_3_MA_1 | ||
| MBH identificatie | MBH_113_3 | ||
Toedieningsafspraken XXX_Dirksz
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_113_1_TA_1 | ||
| Afspraakdatum | 15 jul 2018, om 11:25 | ||
| gebruiksperiode | Vanaf 15 jul 2018, gedurende 30 dagen | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | PRIMPERAN ZETPIL 20MG (code = '229709') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 15 jul 2018, gedurende 30 dagen, zo nodig 1 maal per dag 1 stuk, rectaal | ||
| Toedieningsweg | Rectaal (code = '12') | ||
| Doseerinstructie | Zo nodig 1 maal per dag 1 stuk | ||
| Relatie naar medicatieafspraak | MBH_113_1_MA_1 | ||
| MBH identificatie | MBH_113_1 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_113_2_TA_1 | ||
| Afspraakdatum | 4 aug 2018, om 14:55 | ||
| gebruiksperiode | Vanaf 4 aug 2018, gedurende 3 weken | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | Zestril tabel 10mg (code = '615560') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 4 aug 2018, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| Relatie naar medicatieafspraak | MBH_113_2_MA_1 | ||
| MBH identificatie | MBH_113_2 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_113_3_TA_1 | ||
| Afspraakdatum | 4 aug 2018, om 14:57 | ||
| gebruiksperiode | Vanaf 4 aug 2018, tot nader order | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | ROTER APC TABLET (code = '202185') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 4 aug 2018, tot nader order, 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| Relatie naar medicatieafspraak | MBH_113_2_MA_1 | ||
| MBH identificatie | MBH_113_3 | ||
Verstrekkingen XXX_Dirksz
| Verstrekking | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_113_1_MVE_1 | ||
| Datum | 15 jul 2018, om 12:25 | ||
| Verstrekker | Apotheek de Gulle Gaper | ||
| Verstrekte hoeveelheid | 30 stuks | ||
| Geneesmiddel | PRIMPERAN ZETPIL 20MG (code = '229709') | ||
| Relatie naar verstrekkingsverzoek | MBH_113_1_VV_1 | ||
| MBH identificatie | MBH_113_1 | ||
| Verstrekking | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_113_2_MVE_1 | ||
| Datum | 4 aug 2018, om 15:55 | ||
| Verstrekker | Apotheek de Gulle Gaper | ||
| Verstrekte hoeveelheid | 25 stuks | ||
| Geneesmiddel | Zestril tablet 10mg (code = '615560') | ||
| Relatie naar verstrekkingsverzoek | MBH_113_2_VV_1 | ||
| MBH identificatie | MBH_113_2 | ||
| Verstrekking | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_113_3_MVE_1 | ||
| Datum | 4 aug 2018, om 15:56 | ||
| Verstrekker | Apotheek de Gulle Gaper | ||
| Verstrekte hoeveelheid | 21 stuks | ||
| Geneesmiddel | ROTER APC TABLET (code = '202185') | ||
| Relatie naar verstrekkingsverzoek | MBH_113_3_VV_1 | ||
| MBH identificatie | MBH_113_3 | ||
Medicatiegebruik XXX_Dirksz
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_113_1_MGB_1 | ||
| Registratiedatum | 17 jul 2018, om 11:25 | ||
| Gebruik indicator | True | ||
| gebruiksperiode | Vanaf 17 jul 2018, gedurende 1 dag | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | Metoclopramide zetpil 20mg (code = '6939') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 17 jul 2018, gedurende 1 dag, 1 maal per dag 1 stuk, rectaal | ||
| Toedieningsweg | Rectaal (code = '12') | ||
| Doseerinstructie | Zo nodig 1 maal per dag 1 stuk | ||
| Gerelateerde afspraak: MA | MBH_113_1_MA_1 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_113_1 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_113_2_MGB_1 | ||
| Registratiedatum | 21 aug 2018, om 14:55 | ||
| Gebruik indicator | True | ||
| Volgens afspraak indicator | True | ||
| gebruiksperiode | Vanaf 4 aug 2018, gedurende 3 weken | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | Zestril tabel 10mg (code = '615560') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 4 aug 2018, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| Gerelateerde afspraak: MA | MBH_113_2_MA_1 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_113_2 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_113_3_MGB_1 | ||
| Registratiedatum | 5 aug 2018, om 14:57 | ||
| Gebruik indicator | True | ||
| gebruiksperiode | Vanaf 5 aug 2018, tot en met 26 aug 2018 23:59 | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 5 aug 2018 tot en met 26 aug 2018, 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| Gerelateerde afspraak: MA | MBH_113_3_MA_1 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_113_3 | ||
Patiënt R. XXX_Gobee
| Patient | |||
| Gegevenselement | Waarde | ||
| Naamgegevens | R. XXX_Gobee | ||
| Patient identificatienummer | 999911314 [BSN] | ||
| Patient identificatienummer | 21104 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
| Geboortedatum | 1 aug 1964 | ||
| Geslacht | Vrouw (code = 'F') | ||
Medicatieafspraken XXX_Gobee
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_213_1_MA_1 | ||
| Afspraakdatum | 15 jul 2018, om 11:25 | ||
| gebruiksperiode | Vanaf 15 jul 2018, tot nader order | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
| Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 15 jul 2018, gedurende 30 dagen, 1 à 2 maal per dag 1 tablet, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 à 2 maal per dag 1 stuk | ||
| MBH identificatie | MBH_213_1 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_213_1_MA_2 | ||
| Afspraakdatum | 25 jul 2018, om 09:13 | ||
| gebruiksperiode | Vanaf 15 jul 2018, tot en met 24 jul 2018 23:59 | ||
| Stoptype | Staking | ||
| Relatie naar afspraak of gebruik: MA | MBH_213_1_MA_1 | ||
| Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 15 jul 2018 tot en met 24 jul 2018, 1 à 2 maal per dag 1 tablet, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 à 2 maal per dag 1 stuk | ||
| MBH identificatie | MBH_213_1 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_213_1_MA_3 | ||
| Afspraakdatum | 25 jul 2018, om 09:13 | ||
| gebruiksperiode | Vanaf 25 jul 2018, gedurende 30 dagen | ||
| Relatie naar afspraak of gebruik: MA | MBH_213_1_MA_2 | ||
| Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Geen of onvoldoende effect (code = '5') | ||
| Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 25 jul 2018, gedurende 30 dagen, 2 maal per dag 1 tablet, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 2 maal per dag 1 stuk | ||
| MBH identificatie | MBH_213_1 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_213_1_MA_4 | ||
| Afspraakdatum | 19 aug 2018, om 09:13 | ||
| gebruiksperiode | Vanaf 25 jul 2018, tot en met 19 aug 2018 23:59 | ||
| Stoptype | Staking | ||
| Relatie naar afspraak of gebruik: MA | MBH_213_1_MA_3 | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 25 jul 2018 tot en met 19 aug 2018, 2 maal per dag 1 tablet, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 2 maal per dag 1 stuk | ||
| MBH identificatie | MBH_213_1 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_213_1_MA_5 | ||
| Afspraakdatum | 20 aug 2018, om 16:25 | ||
| gebruiksperiode | Vanaf 20 aug 2018, gedurende 30 dagen | ||
| Relatie naar afspraak of gebruik: MA | MBH_213_1_MA_4 | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Wens patiënt (code = '12') | ||
| Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 20 aug 2018, gedurende 30 dagen, 1 maal per dag 1 tablet, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_213_1 | ||
Verstrekkingsverzoeken XXX_Gobee
| Verstrekkingsverzoek | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_213_1_VV_1 | ||
| Datum | 15 jul 2018, om 11:25 | ||
| Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Te verstrekken hoeveelheid | 40 stuks | ||
| Aantal herhalingen | 1 | ||
| Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
| Beoogd verstrekker | Apotheek De Gulle Gaper | ||
| Relatie naar medicatieafspraak | MBH_213_1_MA_1 | ||
| MBH identificatie | MBH_213_1 | ||
| Verstrekkingsverzoek | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_213_1_VV_2 | ||
| Datum | 25 jul 2018, om 09:13 | ||
| Auteur | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Te verstrekken hoeveelheid | 60 stuks | ||
| Aantal herhalingen | 1 | ||
| Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
| Beoogd verstrekker | Apotheek De Gulle Gaper | ||
| Relatie naar medicatieafspraak | MBH_213_1_MA_3 | ||
| MBH identificatie | MBH_213_1 | ||
| Verstrekkingsverzoek | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_213_1_VV_3 | ||
| Datum | 19 aug 2018, om 16:25 | ||
| Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
| Verbruiksperiode | Vanaf 1 aug 2018, gedurende 30 dagen | ||
| Beoogd verstrekker | Apotheek De Gulle Gaper | ||
| Relatie naar medicatieafspraak | MBH_213_1_MA_5 | ||
| MBH identificatie | MBH_213_1 | ||
Toedieningsafspraken XXX_Gobee
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_213_1_TA_1 | ||
| Afspraakdatum | 15 jul 2018, om 11:25 | ||
| gebruiksperiode | Vanaf 15 jul 2018, tot nader order | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 15 jul 2018, gedurende 30 dagen, 1 à 2 maal per dag 1 tablet, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 à 2 maal per dag 1 stuk | ||
| Relatie naar medicatieafspraak | MBH_213_1_MA_1 | ||
| MBH identificatie | MBH_213_1 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_213_1_TA_2 | ||
| Afspraakdatum | 25 jul 2018, om 09:13 | ||
| gebruiksperiode | Vanaf 15 jul 2018, tot en met 24 jul 2018 23:59 | ||
| Stoptype | Staking | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 15 jul 2018 tot en met 24 jul 2018, 1 à 2 maal per dag 1 tablet, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 à 2 maal per dag 1 stuk | ||
| Relatie naar medicatieafspraak | MBH_213_1_MA_2 | ||
| MBH identificatie | MBH_213_1 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_213_1_TA_3 | ||
| Afspraakdatum | 25 jul 2018, om 09:13 | ||
| gebruiksperiode | Vanaf 25 jul 2018, gedurende 30 dagen | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 25 jul 2018, gedurende 30 dagen, 2 maal per dag 1 tablet, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 2 maal per dag 1 stuk | ||
| Relatie naar medicatieafspraak | MBH_213_1_MA_3 | ||
| MBH identificatie | MBH_213_1 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_213_1_TA_4 | ||
| Afspraakdatum | 19 aug 2018, om 09:13 | ||
| gebruiksperiode | Vanaf 25 jul 2018, tot en met 19 aug 2018 23:59 | ||
| Stoptype | Staking | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 25 jul 2018 tot en met 19 aug 2018, 2 maal per dag 1 tablet, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 2 maal per dag 1 stuk | ||
| Relatie naar medicatieafspraak | MBH_213_1_MA_4 | ||
| MBH identificatie | MBH_213_1 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_213_1_TA_5 | ||
| Afspraakdatum | 19 aug 2018, om 16:25 | ||
| gebruiksperiode | Vanaf 20 aug 2018, gedurende 30 dagen | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 20 aug 2018, gedurende 30 dagen, 1 maal per dag 1 tablet, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| Relatie naar medicatieafspraak | MBH_213_1_MA_5 | ||
| MBH identificatie | MBH_213_1 | ||
Verstrekkingen XXX_Gobee
| Verstrekking | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_213_1_MVE_1 | ||
| Datum | 15 jul 2018, om 13:25 | ||
| Verstrekker | Apotheek de Gulle Gaper | ||
| Verstrekte hoeveelheid | 40 stuks | ||
| Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
| Relatie naar verstrekkingsverzoek | MBH_213_1_VV_1 | ||
| MBH identificatie | MBH_213_1 | ||
| Verstrekking | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_213_1_MVE_2 | ||
| Datum | 25 jul 2018, om 09:13 | ||
| Verstrekker | Apotheek de Gulle Gaper | ||
| Verstrekte hoeveelheid | 60 stuks | ||
| Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
| Relatie naar verstrekkingsverzoek | MBH_213_1_VV_2 | ||
| MBH identificatie | MBH_213_1 | ||
| Verstrekking | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_213_1_MVE_3 | ||
| Datum | 19 aug 2018, om 17:25 | ||
| Verstrekker | Apotheek de Gulle Gaper | ||
| Verstrekte hoeveelheid | 30 stuks | ||
| Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
| Verbruiksduur | 30 dagen | ||
| Relatie naar verstrekkingsverzoek | MBH_213_1_VV_2 | ||
| MBH identificatie | MBH_213_1 | ||
Medicatiegebruik XXX_Gobee
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_213_1_MGB_1 | ||
| Registratiedatum | 18 jul 2018, om 11:25 | ||
| Gebruik indicator | True | ||
| gebruiksperiode | Vanaf 15 jul 2018, gedurende 3 dagen | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 15 jul 2018, gedurende 3 dagen, 1 maal per dag 1 tablet, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| Gerelateerde afspraak: MA | MBH_213_1_MA_1 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_213_1 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_213_1_MGB_2 | ||
| Registratiedatum | 24 jul 2018, om 11:25 | ||
| Gebruik indicator | True | ||
| gebruiksperiode | Vanaf 19 jul 2018, gedurende 6 dagen | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 19 jul 2018, gedurende 6 dagen, 2 maal per dag 1 tablet, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 2 maal per dag 1 stuk | ||
| Gerelateerde afspraak: MA | MBH_213_1_MA_1 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_213_1 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_213_1_MGB_3 | ||
| Registratiedatum | 30 jul 2018, om 19:25 | ||
| Gebruik indicator | True | ||
| gebruiksperiode | Vanaf 25 jul 2018, gedurende 6 dagen | ||
| Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 25 jul 2018, gedurende 6 dagen, 2 maal per dag 1 tablet, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 2 maal per dag 1 stuk | ||
| Gerelateerde afspraak: TA | MBH_213_1_TA_3 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_213_1 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_213_1_MGB_4 | ||
| Registratiedatum | 18 aug 2018, om 11:25 | ||
| Gebruik indicator | True | ||
| gebruiksperiode | Vanaf 31 jul 2018, gedurende 19 dagen | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 31 jul 2018, gedurende 19 dagen, 2 maal per dag 1 tablet, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 2 maal per dag 1 stuk | ||
| Gerelateerde afspraak: MA | MBH_213_1_MA_3 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_213_1 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_213_1_MGB_5 | ||
| Registratiedatum | 24 aug 2018, om 11:25 | ||
| Gebruik indicator | True | ||
| gebruiksperiode | Vanaf 20 aug 2018, gedurende 5 dagen | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 20 aug 2018, gedurende 5 dagen, 1 maal per dag 1 tablet, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| Gerelateerde afspraak: MA | MBH_213_1_MA_5 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_213_1 | ||
Patiënt J. XXX_Kilkenny
| Patient | |||
| Gegevenselement | Waarde | ||
| Naamgegevens | J. XXX_Kilkenny | ||
| Patient identificatienummer | 999911752 [BSN] | ||
| Patient identificatienummer | 22108 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
| Geboortedatum | 5 aug 1964 | ||
| Geslacht | Vrouw (code = 'F') | ||
Medicatieafspraken XXX_Kilkenny
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_323_1_MA_1 | ||
| Afspraakdatum | 29 aug 2018, om 15:34 | ||
| gebruiksperiode | Vanaf 14 aug 2018, tot en met 28 aug 2018 23:59 | ||
| Stoptype | Staking | ||
| Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | ADVIL BRUIS BRUISTABLET 400MG CITRUSSMAAK (code = '2121522') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 14 aug 2018 tot en met 28 aug 2018, 3x per dag 1 tablet | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 3 maal per dag 1 stuk | ||
| MBH identificatie | MBH_323_1 | ||
Medicatiegebruik XXX_Kilkenny
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_323_1_MGB_1 | ||
| Registratiedatum | 24 aug 2018, om 11:25 | ||
| Gebruik indicator | True | ||
| gebruiksperiode | Vanaf 14 aug 2018, tot nader order | ||
| Geneesmiddel | ADVIL BRUIS BRUISTABLET 400MG CITRUSSMAAK (code = '2121522') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 14 aug 2018, 3x per dag 1 tablet, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 3 maal per dag 1 stuk | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_323_1 | ||
Patiënt R. XXX_Ruys
| Patient | |||
| Gegevenselement | Waarde | ||
| Naamgegevens | R. XXX_Ruys | ||
| Patient identificatienummer | 999911351 [BSN] | ||
| Patient identificatienummer | 13103 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
| Geboortedatum | 1 aug 1964 | ||
| Geslacht | Man (code = 'M') | ||
Patiënt R. XXX_Strengersz
| Patient | |||
| Gegevenselement | Waarde | ||
| Naamgegevens | R. XXX_Strengersz | ||
| Patient identificatienummer | 999911338 [BSN] | ||
| Patient identificatienummer | 41106 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
| Geboortedatum | 1 aug 1964 | ||
| Geslacht | Vrouw (code = 'F') | ||
Medicatieafspraken XXX_Strengersz
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_1_MA_1 | ||
| Afspraakdatum | 3 sep 2018, om 11:25 | ||
| gebruiksperiode | Vanaf 3 sep 2018, gedurende 60 dagen | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
| Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 à 2 maal per dag 1 stuk | ||
| MBH identificatie | MBH_413_1 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_2_MA_1 | ||
| Afspraakdatum | 3 sep 2018, om 11:25 | ||
| gebruiksperiode | Vanaf 3 sep 2018, gedurende 60 dagen | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
| Geneesmiddel | Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, gedurende 60 dagen, exact iedere 3 uur 16 IE, subcutaan | ||
| Toedieningsweg | Subcutaan (code = '21') | ||
| Doseerinstructie | Exact iedere 3 uur 16 internationale eenheid | ||
| MBH identificatie | MBH_413_2 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_3_MA_1 | ||
| Afspraakdatum | 15 jul 2018, om 11:25 | ||
| gebruiksperiode | Vanaf 15 jul 2018, gedurende 7 weken | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
| Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 15 jul 2018, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 3 maal per dag 1 à 2 stuks | ||
| MBH identificatie | MBH_413_3 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_4_MA_1 | ||
| Afspraakdatum | 14 aug 2018, om 10:26 | ||
| gebruiksperiode | Vanaf 14 aug 2018, gedurende 30 dagen | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
| Geneesmiddel | Cetomacrogolcreme met vaseline 10% (code = '92789') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 14 aug 2018, gedurende 30 dagen, 3 maal per dag aanbrengen, cutaan | ||
| Toedieningsweg | Cutaan (code = '7') | ||
| Aanvullende instructie | Aanbrengen (code = '1018') | ||
| Doseerinstructie | 3 maal per dag | ||
| MBH identificatie | MBH_413_4 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_5_MA_1 | ||
| Afspraakdatum | 14 aug 2018, om 10:46 | ||
| gebruiksperiode | Vanaf 14 aug 2018, gedurende 30 dagen | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
| Geneesmiddel | Ibuprofen PCH tablet 600mg (code = '641898') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 14 aug 2018, gedurende 30 dagen, 2 maal per dag ¼ tablet | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 2 maal per dag 0.25 stuk | ||
| MBH identificatie | MBH_413_5 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_6_MA_1 | ||
| Afspraakdatum | 3 sep 2018, om 09:35 | ||
| gebruiksperiode | Vanaf 3 sep 2018, gedurende 14 dagen | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
| Geneesmiddel | Waterstofperoxide 30MG/ML (code = '67016') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, gedurende 14 dagen, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | ||
| Toedieningsweg | Niet van toepassing (code = '1') | ||
| Aanvullende instructie | Eerst oplossen in water (code = '27') | ||
| Aanvullende instructie | Mond spoelen, daarna uitspugen (code = '69') | ||
| Doseerinstructie | 2 maal per dag 10 à 15 ml | ||
| MBH identificatie | MBH_413_6 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_7_MA_1 | ||
| Afspraakdatum | 3 sep 2018, om 09:35 | ||
| gebruiksperiode | Vanaf 3 sep 2018, gedurende 14 dagen | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
| Geneesmiddel | Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, gedurende 14 dagen, elke dag om 08:00, 14:00 en 20:00 uur 16IE | ||
| Toedieningsweg | Subcutaan (code = '21') | ||
| Doseerinstructie | Elke dag om 08:00, 14:00 en 20:00 16 internationale eenheid | ||
| MBH identificatie | MBH_413_7 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_8_MA_1 | ||
| Afspraakdatum | 3 sep 2018, om 09:35 | ||
| gebruiksperiode | Vanaf 3 sep 2018, gedurende 10 weken | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
| Geneesmiddel | IMIQUIMOD 50MG/G CREME (code = '55050') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen | ||
| Toedieningsweg | Subcutaan (code = '21') | ||
| Aanvullende instructie | Voor de nacht (code = '1128') | ||
| Aanvullende instructie | Aanbrengen (code = '1018') | ||
| Doseerinstructie | Op maandag, woensdag en vrijdag | ||
| MBH identificatie | MBH_413_8 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_9_MA_1 | ||
| Afspraakdatum | 3 sep 2018, om 09:35 | ||
| gebruiksperiode | Vanaf 3 sep 2018, tot nader order | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
| Geneesmiddel | EZETIMIB/SIMVASTATINE 10/20 (code = '77038') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, 1 maal daags 1 stuk ’s avonds innemen, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk 's avonds | ||
| MBH identificatie | MBH_413_9 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_10_MA_1 | ||
| Afspraakdatum | 3 sep 2018, om 09:35 | ||
| gebruiksperiode | Vanaf 3 sep 2018, tot nader order | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
| Geneesmiddel | Ethinyl estradiol/desogestrel tablet 30/150ug (Marvelon) (code = '16292') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | Gedurende 21 dagen 1 maal per dag 1 stuk | ||
| Herhaalperiode cyclisch schema | 28 dagen | ||
| MBH identificatie | MBH_413_10 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_11_MA_1 | ||
| Afspraakdatum | 3 sep 2018, om 09:35 | ||
| gebruiksperiode | Vanaf 3 sep 2018, gedurende 41 dagen | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
| Geneesmiddel | Fusidinezuur creme 20mg/g (code = '16705') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | ||
| Toedieningsweg | Cutaan (code = '7') | ||
| Aanvullende instructie | Dun aanbrengen (code = '1033') | ||
| Doseerinstructie 1 | Eerst gedurende 2 weken 1 maal per dag 3 gram | ||
| Doseerinstructie 2 | Dan gedurende 3 weken 1 maal per dag 2 gram | ||
| Doseerinstructie 3 | Dan gedurende 6 dagen 1 maal per dag 1 gram | ||
| MBH identificatie | MBH_413_11 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_12_MA_1 | ||
| Afspraakdatum | 3 sep 2018, om 11:25 | ||
| gebruiksperiode | Vanaf 3 sep 2018, gedurende 3 weken | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
| Geneesmiddel | CODEINE TABLET 10MG (FOSFAAT) (code = '42773') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | Bij hoest 3 à 4 maal per uur 1 stuk | ||
| MBH identificatie | MBH_413_12 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_13_MA_1 | ||
| Afspraakdatum | 6 aug 2018, om 09:12 | ||
| gebruiksperiode | Vanaf 6 aug 2018, gedurende 8 dagen | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
| Geneesmiddel | MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 6 aug 2018, gedurende 8 dagen, 0.5 ml per uur parenteraal | ||
| Toedieningsweg | Parenteraal (code = '10') | ||
| Doseerinstructie | 0.5 ml per uur | ||
| MBH identificatie | MBH_413_13 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_13_MA_2 | ||
| Afspraakdatum | 14 aug 2018, om 11:25 | ||
| gebruiksperiode | Vanaf 14 aug 2018, gedurende 8 dagen | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
| Geneesmiddel | MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 14 aug 2018, gedurende 8 dagen, 0.2 tot 0.5 ml per uur parenteraal | ||
| Toedieningsweg | Parenteraal (code = '10') | ||
| Doseerinstructie | 0.2 à 0.5 ml per uur | ||
| MBH identificatie | MBH_413_13 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_14_MA_1 | ||
| Afspraakdatum | 3 sep 2018, om 11:25 | ||
| gebruiksperiode | Tot nader order | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
| Geneesmiddel | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520') | ||
| Gebruiksinstructie | |||
| Omschrijving | Tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister), transdermaal | ||
| Toedieningsweg | Transdermaal (code = '58') | ||
| Doseerinstructie | 1 maal per dag 1 stuk gedurende 16 uur | ||
| MBH identificatie | MBH_413_14 | ||
| Medicatieafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_15_MA_1 | ||
| Afspraakdatum | 3 sep 2018, om 09:35 | ||
| gebruiksperiode | Vanaf 3 sep 2018, gedurende 4 dagen | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Reden afspraak | Starten medicamenteuze behandeling (code = '266709005') | ||
| Geneesmiddel - Product specificatie | |||
| Product naam | Haparine 100 ie= 10 ml | ||
| Omschrijving | Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | ||
| Farmaceutische vorm | Vloeistof (code = '434') | ||
| Ingredient | |||
| Ingredient code | Heparinum natricum (code = '898724') | ||
| Sterkte | 100 internationale eenheid per 10 ml | ||
| Ingredient | |||
| Ingredient code | WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610') | ||
| Sterkte | 1 stuk per 10 ml | ||
| Ingredient | |||
| Ingredient code | NATRII CHLORIDUM (code = '256390') | ||
| Sterkte | 0.09 gram per 10 ml | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, gedurende 4 dagen, 2 maal per dag 10 ml, parenteraal | ||
| Toedieningsweg | Parenteraal (code = '10') | ||
| Doseerinstructie | 2 maal per dag 10 ml | ||
| MBH identificatie | MBH_413_15 | ||
Verstrekkingsverzoeken XXX_Strengersz
| Verstrekkingsverzoek | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_15_VV_1 | ||
| Datum | 3 sep 2018, om 09:35 | ||
| Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Te verstrekken hoeveelheid | 100 ml | ||
| Aantal herhalingen | 1 | ||
| Geneesmiddel - Product specificatie | |||
| Product naam | Haparine 100 ie= 10 ml | ||
| Omschrijving | Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | ||
| Farmaceutische vorm | Vloeistof (code = '434') | ||
| Ingredient | |||
| Ingredient code | Heparinum natricum (code = '898724') | ||
| Sterkte | 100 internationale eenheid per 10 ml | ||
| Ingredient | |||
| Ingredient code | WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610') | ||
| Sterkte | 1 stuk per 10 ml | ||
| Ingredient | |||
| Ingredient code | NATRII CHLORIDUM (code = '256390') | ||
| Sterkte | 0.09 gram per 10 ml | ||
| Beoogd verstrekker | Apotheek De Gulle Gaper | ||
| Relatie naar medicatieafspraak | MBH_413_15_MA_1 | ||
| MBH identificatie | MBH_413_15 | ||
Toedieningsafspraken XXX_Strengersz
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_1_TA_1 | ||
| Afspraakdatum | 3 sep 2018, om 11:25 | ||
| gebruiksperiode | Vanaf 3 sep 2018, gedurende 60 dagen | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 à 2 maal per dag 1 stuk | ||
| Relatie naar medicatieafspraak | MBH_413_1_MA_1 | ||
| MBH identificatie | MBH_413_1 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_2_TA_1 | ||
| Afspraakdatum | 3 sep 2018, om 11:25 | ||
| gebruiksperiode | Vanaf 3 sep 2018, gedurende 60 dagen | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | HUMULINE NPH INJ 100IE/ML PATROON 3ML (code = '870471') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, gedurende 60 dagen, exact iedere 3 uur 16 IE, subcutaan | ||
| Toedieningsweg | Subcutaan (code = '21') | ||
| Doseerinstructie | Exact iedere 3 uur 16 internationale eenheid | ||
| Relatie naar medicatieafspraak | MBH_413_2_MA_1 | ||
| MBH identificatie | MBH_413_2 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_3_TA_1 | ||
| Afspraakdatum | 15 jul 2018, om 11:25 | ||
| gebruiksperiode | Vanaf 15 jul 2018, gedurende 7 weken | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 15 jul 2018, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 3 maal per dag 1 à 2 stuks | ||
| Relatie naar medicatieafspraak | MBH_413_3_MA_1 | ||
| MBH identificatie | MBH_413_3 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_4_TA_1 | ||
| Afspraakdatum | 14 aug 2018, om 10:26 | ||
| gebruiksperiode | Vanaf 14 aug 2018, gedurende 30 dagen | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 14 aug 2018, gedurende 30 dagen, 3 maal per dag aanbrengen, cutaan | ||
| Toedieningsweg | Cutaan (code = '7') | ||
| Aanvullende instructie | Aanbrengen (code = '1018') | ||
| Doseerinstructie | 3 maal per dag | ||
| Relatie naar medicatieafspraak | MBH_413_4_MA_1 | ||
| MBH identificatie | MBH_413_4 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_5_TA_1 | ||
| Afspraakdatum | 14 aug 2018, om 10:46 | ||
| gebruiksperiode | Vanaf 14 aug 2018, gedurende 30 dagen | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | Ibuprofen PCH tablet 600mg (code = '641898') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 14 aug 2018, gedurende 30 dagen, 2 maal per dag ¼ tablet, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 2 maal per dag 0.25 stuk | ||
| Relatie naar medicatieafspraak | MBH_413_5_MA_1 | ||
| MBH identificatie | MBH_413_5 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_6_TA_1 | ||
| Afspraakdatum | 3 sep 2018, om 09:35 | ||
| gebruiksperiode | Vanaf 3 sep 2018, gedurende 14 dagen | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | SOLUTIO HYDROGENII PEROXIDI 3% M/V (code = '603694') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, gedurende 14 dagen, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | ||
| Toedieningsweg | Niet van toepassing (code = '1') | ||
| Aanvullende instructie | Eerst oplossen in water (code = '27') | ||
| Aanvullende instructie | Mond spoelen, daarna uitspugen (code = '69') | ||
| Doseerinstructie | 2 maal per dag 10 à 15 ml | ||
| Relatie naar medicatieafspraak | MBH_413_6_MA_1 | ||
| MBH identificatie | MBH_413_6 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_7_TA_1 | ||
| Afspraakdatum | 3 sep 2018, om 09:35 | ||
| gebruiksperiode | Vanaf 3 sep 2018, gedurende 14 dagen | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | HUMULINE NPH INJ 100IE/ML PATROON 3ML (code = '870471') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, gedurende 14 dagen, elke dag om 08:00, 14:00 en 20:00 uur 16IE, subcutaan | ||
| Toedieningsweg | Subcutaan (code = '21') | ||
| Doseerinstructie | Elke dag om 08:00, 14:00 en 20:00 16 internationale eenheid | ||
| Relatie naar medicatieafspraak | MBH_413_7_MA_1 | ||
| MBH identificatie | MBH_413_7 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_8_TA_1 | ||
| Afspraakdatum | 3 sep 2018, om 09:35 | ||
| gebruiksperiode | Vanaf 3 sep 2018, gedurende 10 weken | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | ALDARA CREME 50MG/G IN SACHET (code = '1198521') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen, cutaan | ||
| Toedieningsweg | Subcutaan (code = '21') | ||
| Aanvullende instructie | Voor de nacht (code = '1128') | ||
| Aanvullende instructie | Aanbrengen (code = '1018') | ||
| Doseerinstructie | Op maandag, woensdag en vrijdag | ||
| Relatie naar medicatieafspraak | MBH_413_8_MA_1 | ||
| MBH identificatie | MBH_413_8 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_9_TA_1 | ||
| Afspraakdatum | 3 sep 2018, om 09:35 | ||
| gebruiksperiode | Vanaf 3 sep 2018, tot nader order | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | INEGY TABLET 10/20MG (code = '1719785') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, tot nader order, 1 maal daags 1 stuk ’s avonds innemen, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk 's avonds | ||
| Relatie naar medicatieafspraak | MBH_413_9_MA_1 | ||
| MBH identificatie | MBH_413_9 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_10_TA_1 | ||
| Afspraakdatum | 3 sep 2018, om 09:35 | ||
| gebruiksperiode | Vanaf 3 sep 2018, tot nader order | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | MARVELON TABLET (code = '416681') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | Gedurende 21 dagen 1 maal per dag 1 stuk | ||
| Herhaalperiode cyclisch schema | 28 dagen | ||
| Relatie naar medicatieafspraak | MBH_413_10_MA_1 | ||
| MBH identificatie | MBH_413_10 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_11_TA_1 | ||
| Afspraakdatum | 3 sep 2018, om 09:35 | ||
| gebruiksperiode | Vanaf 3 sep 2018, gedurende 41 dagen | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | FUCIDIN CREME 20MG/G (code = '420956') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | ||
| Toedieningsweg | Cutaan (code = '7') | ||
| Aanvullende instructie | Dun aanbrengen (code = '1033') | ||
| Doseerinstructie 1 | Eerst gedurende 2 weken 1 maal per dag 3 gram | ||
| Doseerinstructie 2 | Dan gedurende 3 weken 1 maal per dag 2 gram | ||
| Doseerinstructie 3 | Dan gedurende 6 dagen 1 maal per dag 1 gram | ||
| Relatie naar medicatieafspraak | MBH_413_11_MA_1 | ||
| MBH identificatie | MBH_413_11 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_12_TA_1 | ||
| Afspraakdatum | 3 sep 2018, om 11:25 | ||
| gebruiksperiode | Vanaf 3 sep 2018, gedurende 3 weken | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | CODEINEFOSFAAT PCH TABLET 10MG (code = '874965') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | Bij hoest 3 à 4 maal per uur 1 stuk | ||
| Relatie naar medicatieafspraak | MBH_413_12_MA_1 | ||
| MBH identificatie | MBH_413_12 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_13_TA_1 | ||
| Afspraakdatum | 6 aug 2018, om 09:12 | ||
| gebruiksperiode | Vanaf 6 aug 2018, gedurende 8 dagen | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | MORFINEHYDROCHLORIDE 5MG/ML DELTEC CAS 100ML PA (code = '2124823') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 6 aug 2018, gedurende 8 dagen, 0.5 ml per uur parenteraal | ||
| Toedieningsweg | Parenteraal (code = '10') | ||
| Doseerinstructie | 0.5 ml per uur | ||
| Relatie naar medicatieafspraak | MBH_413_13_MA_1 | ||
| MBH identificatie | MBH_413_13 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_13_TA_2 | ||
| Afspraakdatum | 14 aug 2018, om 11:25 | ||
| gebruiksperiode | Vanaf 14 aug 2018, gedurende 8 dagen | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | MORFINEHYDROCHLORIDE 5MG/ML DELTEC CAS 100ML PA (code = '2124823') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 14 aug 2018, gedurende 8 dagen, 0.2 tot 0.5 ml per uur parenteraal | ||
| Toedieningsweg | Parenteraal (code = '10') | ||
| Doseerinstructie | 0.2 à 0.5 ml per uur | ||
| Relatie naar medicatieafspraak | MBH_413_13_MA_2 | ||
| MBH identificatie | MBH_413_13 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_14_TA_1 | ||
| Afspraakdatum | 3 sep 2018, om 11:25 | ||
| gebruiksperiode | Vanaf 16 aug 2018, tot nader order | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel | DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG (code = '1013602') | ||
| Gebruiksinstructie | |||
| Omschrijving | Tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister), transdermaal | ||
| Toedieningsweg | Transdermaal (code = '58') | ||
| Doseerinstructie | 1 maal per dag 1 stuk gedurende 16 uur | ||
| Relatie naar medicatieafspraak | MBH_413_14_MA_1 | ||
| MBH identificatie | MBH_413_14 | ||
| Toedieningsafspraak | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_15_TA_1 | ||
| Afspraakdatum | 3 sep 2018, om 09:35 | ||
| gebruiksperiode | Vanaf 3 sep 2018, gedurende 4 dagen | ||
| Verstrekker | Apotheek De Gulle Gaper | ||
| Geneesmiddel - Product specificatie | |||
| Product naam | Haparine 100 ie= 10 ml | ||
| Omschrijving | Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | ||
| Farmaceutische vorm | Vloeistof (code = '434') | ||
| Ingredient | |||
| Ingredient code | Heparinum natricum (code = '898724') | ||
| Sterkte | 100 internationale eenheid per 10 ml | ||
| Ingredient | |||
| Ingredient code | WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610') | ||
| Sterkte | 1 stuk per 10 ml | ||
| Ingredient | |||
| Ingredient code | NATRII CHLORIDUM (code = '256390') | ||
| Sterkte | 0.09 gram per 10 ml | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, gedurende 4 dagen, 2 maal per dag 10 ml, parenteraal | ||
| Toedieningsweg | Parenteraal (code = '10') | ||
| Doseerinstructie | 2 maal per dag 10 ml | ||
| Relatie naar medicatieafspraak | MBH_413_15_MA_1 | ||
| MBH identificatie | MBH_413_15 | ||
Verstrekkingen XXX_Strengersz
| Verstrekking | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_9_MVE_1 | ||
| Datum | 3 sep 2018, om 10:35 | ||
| Verstrekker | Apotheek de Gulle Gaper | ||
| Verstrekte hoeveelheid | 90 stuks | ||
| Geneesmiddel | INEGY TABLET 10/20MG (code = '1719785') | ||
| Distributievorm | Geïndividualiseerd distributiesysteem (code = '1') | ||
| MBH identificatie | MBH_413_9 | ||
| Verstrekking | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_15_MVE_1 | ||
| Datum | 3 sep 2018, om 10:35 | ||
| Verstrekker | Apotheek de Gulle Gaper | ||
| Verstrekte hoeveelheid | 100 ml | ||
| Geneesmiddel - Product specificatie | |||
| Product naam | Haparine 100 ie= 10 ml | ||
| Omschrijving | Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | ||
| Farmaceutische vorm | Vloeistof (code = '434') | ||
| Ingredient | |||
| Ingredient code | Heparinum natricum (code = '898724') | ||
| Sterkte | 100 internationale eenheid per 10 ml | ||
| Ingredient | |||
| Ingredient code | WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610') | ||
| Sterkte | 1 stuk per 10 ml | ||
| Ingredient | |||
| Ingredient code | NATRII CHLORIDUM (code = '256390') | ||
| Sterkte | 0.09 gram per 10 ml | ||
| Relatie naar verstrekkingsverzoek | MBH_513_15_VV_1 | ||
| MBH identificatie | MBH_413_15 | ||
Medicatiegebruik XXX_Strengersz
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_1_MGB_1 | ||
| Registratiedatum | 3 sep 2018, om 16:25 | ||
| Gebruik indicator | True | ||
| Volgens afspraak indicator | True | ||
| gebruiksperiode | Vanaf 3 sep 2018, gedurende 60 dagen | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 à 2 maal per dag 1 stuk | ||
| Gerelateerde afspraak: MA | MBH_413_1_MA_1 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_413_1 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_2_MGB_1 | ||
| Registratiedatum | 3 sep 2018, om 14:25 | ||
| Gebruik indicator | True | ||
| gebruiksperiode | Vanaf 3 sep 2018, gedurende 14 dagen | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, gedurende 14 dagen, exact iedere 3 uur 16 IE, subcutaan | ||
| Toedieningsweg | Subcutaan (code = '21') | ||
| Doseerinstructie | Exact iedere 3 uur 16 internationale eenheid | ||
| Gerelateerde afspraak: MA | MBH_413_2_MA_1 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_413_2 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_3_MGB_1 | ||
| Registratiedatum | 3 sep 2018, om 10:45 | ||
| Gebruik indicator | True | ||
| Volgens afspraak indicator | True | ||
| gebruiksperiode | Vanaf 15 jul 2018, gedurende 7 weken | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 15 jul 2018, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 3 maal per dag 1 à 2 stuks | ||
| Gerelateerde afspraak: MA | MBH_413_3_MA_1 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_413_3 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_4_MGB_1 | ||
| Registratiedatum | 19 aug 2018, om 13:44 | ||
| Gebruik indicator | True | ||
| gebruiksperiode | Vanaf 14 aug 2018, tot en met 19 aug 2018 23:59 | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | Cetomacrogolcreme met vaseline 10% (code = '92789') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 14 aug 2018 tot en met 19 aug 2018, 3 maal per dag aanbrengen, cutaan | ||
| Toedieningsweg | Cutaan (code = '7') | ||
| Aanvullende instructie | Aanbrengen (code = '1018') | ||
| Doseerinstructie | 3 maal per dag | ||
| Gerelateerde afspraak: MA | MBH_413_4_MA_1 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_413_4 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_5_MGB_1 | ||
| Registratiedatum | 3 sep 2018, om 12:38 | ||
| Gebruik indicator | True | ||
| gebruiksperiode | Vanaf 14 aug 2018, gedurende 30 dagen | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | Ibuprofen PCH tablet 600mg (code = '641898') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 14 aug 2018, gedurende 30 dagen, 2 maal per dag ¼ tablet | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 2 maal per dag 0.25 stuk | ||
| Gerelateerde afspraak: MA | MBH_413_5_MA_1 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_413_5 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_6_MGB_1 | ||
| Registratiedatum | 3 sep 2018, om 21:37 | ||
| Gebruik indicator | True | ||
| gebruiksperiode | Vanaf 3 sep 2018, gedurende 1 dag | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | Waterstofperoxide 30MG/ML (code = '67016') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, gedurende 1 dag, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | ||
| Toedieningsweg | Niet van toepassing (code = '1') | ||
| Aanvullende instructie | Eerst oplossen in water (code = '27') | ||
| Aanvullende instructie | Mond spoelen, daarna uitspugen (code = '69') | ||
| Doseerinstructie | 2 maal per dag 10 à 15 ml | ||
| Gerelateerde afspraak: MA | MBH_413_6_MA_1 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_413_6 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_7_MGB_1 | ||
| Registratiedatum | 3 sep 2018, om 14:05 | ||
| Gebruik indicator | True | ||
| gebruiksperiode | Vanaf 3 sep 2018 14:00, tot en met 3 sep 2018 14:05 | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018 14:00 tot en met 3 sep 2018 14:05, om 14:00 16IE | ||
| Toedieningsweg | Subcutaan (code = '21') | ||
| Doseerinstructie | Elke dag om 16 internationale eenheid | ||
| Gerelateerde afspraak: MA | MBH_413_7_MA_1 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_413_7 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_7_MGB_2 | ||
| Registratiedatum | 3 sep 2018, om 20:10 | ||
| Gebruik indicator | True | ||
| gebruiksperiode | Vanaf 3 sep 2018 20:00, tot en met 3 sep 2018 20:05 | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018 20:00 tot en met 3 sep 2018 20:05, om 20:00 16IE | ||
| Toedieningsweg | Subcutaan (code = '21') | ||
| Doseerinstructie | Elke dag om 16 internationale eenheid | ||
| Gerelateerde afspraak: MA | MBH_413_7_MA_1 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_413_7 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_8_MGB_1 | ||
| Registratiedatum | 3 sep 2018, om 23:59 | ||
| Gebruik indicator | True | ||
| Volgens afspraak indicator | True | ||
| gebruiksperiode | Vanaf 3 sep 2018, gedurende 10 weken | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | IMIQUIMOD 50MG/G CREME (code = '55050') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen | ||
| Aanvullende instructie | Voor de nacht (code = '1128') | ||
| Aanvullende instructie | Aanbrengen (code = '1018') | ||
| Doseerinstructie | Op maandag, woensdag en vrijdag | ||
| Gerelateerde afspraak: MA | MBH_413_8_MA_1 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_413_8 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_9_MGB_1 | ||
| Registratiedatum | 3 sep 2018, om 22:35 | ||
| Gebruik indicator | True | ||
| Volgens afspraak indicator | True | ||
| gebruiksperiode | Vanaf 3 sep 2018, tot nader order | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | EZETIMIB/SIMVASTATINE 10/20 (code = '77038') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, tot nader order, 1 maal daags ’s avonds innemen | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | 1 maal per dag 1 stuk 's avonds | ||
| Gerelateerde afspraak: MA | MBH_413_9_MA_1 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_413_9 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_10_MGB_1 | ||
| Registratiedatum | 3 sep 2018, om 09:35 | ||
| Gebruik indicator | True | ||
| Volgens afspraak indicator | True | ||
| gebruiksperiode | Vanaf 3 sep 2018, tot nader order | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | Ethinyl estradiol/desogestrel tablet 30/150ug (Marvelon) (code = '16292') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal | ||
| Doseerinstructie | Gedurende 21 dagen 1 maal per dag 1 stuk | ||
| Herhaalperiode cyclisch schema | 28 dagen | ||
| Gerelateerde afspraak: MA | MBH_413_10_MA_1 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_413_10 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_11_MGB_1 | ||
| Registratiedatum | 3 sep 2018, om 15:35 | ||
| Gebruik indicator | True | ||
| Volgens afspraak indicator | True | ||
| gebruiksperiode | Vanaf 3 sep 2018, gedurende 41 dagen | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | Fusidinezuur creme 20mg/g (code = '16705') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | ||
| Aanvullende instructie | Dun aanbrengen (code = '1033') | ||
| Doseerinstructie 1 | Eerst gedurende 2 weken 1 maal per dag 3 gram | ||
| Doseerinstructie | Dan gedurende 3 weken 1 maal per dag 2 gram | ||
| Doseerinstructie | Dan gedurende 6 dagen 1 maal per dag 1 gram | ||
| Gerelateerde afspraak: MA | MBH_413_11_MA_1 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_413_11 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_12_MGB_1 | ||
| Registratiedatum | 3 sep 2018, om 22:35 | ||
| Gebruik indicator | True | ||
| Volgens afspraak indicator | True | ||
| gebruiksperiode | Vanaf 3 sep 2018, gedurende 3 weken | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | CODEINE TABLET 10MG (FOSFAAT) (code = '42773') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | ||
| Toedieningsweg | Oraal (code = '9') | ||
| Doseerinstructie | Bij hoest 3 à 4 maal per uur 1 stuk | ||
| Gerelateerde afspraak: MA | MBH_413_12_MA_1 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_413_12 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_14_MGB_1 | ||
| Registratiedatum | 3 sep 2018, om 22:35 | ||
| Gebruik indicator | True | ||
| Volgens afspraak indicator | True | ||
| gebruiksperiode | Tot nader order | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520') | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister). | ||
| Toedieningsweg | Transdermaal (code = '58') | ||
| Doseerinstructie | 1 maal per dag 1 stuk gedurende 16 uur | ||
| Gerelateerde afspraak: MA | MBH_413_14_MA_1 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_413_14 | ||
| Medicatie gebruik | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_413_15_MGB_1 | ||
| Registratiedatum | 3 sep 2018, om 10:35 | ||
| Gebruik indicator | True | ||
| Volgens afspraak indicator | True | ||
| gebruiksperiode | Vanaf 3 sep 2018, gedurende 4 dagen | ||
| Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
| Geneesmiddel - Product specificatie | |||
| Product naam | Haparine 100 ie= 10 ml | ||
| Omschrijving | Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | ||
| Farmaceutische vorm | Vloeistof (code = '434') | ||
| Ingredient | |||
| Ingredient code | Heparinum natricum (code = '898724') | ||
| Sterkte | 100 internationale eenheid per 10 ml | ||
| Ingredient | |||
| Ingredient code | WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610') | ||
| Sterkte | 1 stuk per 10 ml | ||
| Ingredient | |||
| Ingredient code | NATRII CHLORIDUM (code = '256390') | ||
| Sterkte | 0.09 gram per 10 ml | ||
| Gebruiksinstructie | |||
| Omschrijving | Vanaf 3 sep 2018, gedurende 4 dagen, 2 maal per dag 10 ml | ||
| Toedieningsweg | Parenteraal (code = '10') | ||
| Doseerinstructie | 2 maal per dag 10 ml | ||
| Gerelateerde afspraak: MA | MBH_413_15_MA_1 | ||
| Auteur | Patiënt | ||
| MBH identificatie | MBH_413_15 | ||